1. Introduction
1.1. Circadian Rhythm
Circadian rhythms are internal biological processes following an approximately 24 h cycle, governing physiological and behavioral functions in response to light and darkness. These rhythms are regulated by a complex molecular clock consisting of core clock genes and their protein products, which interact in feedback loops to sustain rhythmicity. In mammals, the suprachiasmatic nucleus (SCN) in the hypothalamus serves as the main circadian clock, aligning physiological and behavioral functions like sleep–wake cycles, hormone release, and metabolism with the day–night cycle [1,2].
In 1971, Seymour Benzer and Ronald Konopka identified the genetic foundation of circadian rhythms by demonstrating that mutations in the Period (Per) gene in Drosophila melanogaster resulted in changes to these rhythms [3]. The PER protein is integral to the circadian clock, acting as a transcription factor in conjunction with TIM (Timeless) to control the expression of other circadian genes. This discovery provided a foundation for Jeffrey Hall, Michael Rosbash, and Michael Young to identify more circadian clock components and clarify the molecular mechanisms of circadian rhythms. Their work demonstrated that PER and CRY (Cryptochrome Circadian Regulator) form a negative feedback loop controlling the circadian cycle [4,5,6,7].
BMAL1 is a basic-helix–loop–helix (bHLH) transcription factor that heterodimerizes with the analogous bHLH transcription factor CLOCK [8]. The CLOCK–BMAL1 complex binds to E-box elements in circadian gene promoters, such as PER and CRY, to initiate their transcription [9]. This interaction is crucial for the maintenance of the circadian rhythm and is conserved across various species from fruit flies to mammals. In mammals, CRY1 and CRY2 proteins are crucial elements of the circadian feedback loop. They interact with PER proteins, causing their degradation and thereby regulating the feedback inhibition of CLOCK–BMAL1 activity [10]. The PER–TIM complex regulates CRY gene expression, contributing to the maintenance of the 24 h biological rhythm [11]. For a detailed summary of the expression and roles of these key proteins in the circadian rhythm, refer to Figure 1 and Table 1.
Since the discovery of the Key Components of Circadian Rhythms, many clock genes encoding transcription factors (TFs) have been cloned and characterized in mammals [15]. Despite significant progress, fundamental questions remain regarding how these molecules influence cellular autonomous rhythms from the transcriptional regulatory level to the physiological rhythms of the entire organism. Investigating how these molecules influence circadian transcription is essential for understanding organismal adaptation to circadian and other periodic environmental changes.
This review highlights recent advances in understanding the transcriptional mechanisms underlying circadian rhythms, particularly the influence of chromatin remodeling and protein modifications on transcriptional regulation, with a specific focus on RNA polymerase II (Pol II) pausing control. It is worth mentioning that by studying the endogenous rhythm mechanisms of organisms, we can apply this knowledge to adjust and optimize human lifestyle rhythms. Examining the impact of clock genes and biological rhythms on human health aids in developing informed lifestyle habits, enhancing physical and mental well-being.
1.2. Core Regulatory Circuits of Circadian Rhythms
Research on the regulatory mechanisms of circadian rhythms is crucial for understanding the operation principles of the biological clock, various activities of organisms, and the occurrence of diseases. We will describe the fundamental mechanisms regulating circadian rhythms in mammals, which underpin our comprehension of these biological cycles.
SCN in the hypothalamus regulates circadian rhythms in mammals by controlling gene expression, metabolism, and electrophysiological activities in response to light and other environmental cues [16,17,18]. The SCN’s biological clock structure is a transcriptional–translational negative feedback loop involving key proteins such as CLOCK and BMAL1, which bind to E-box elements in promoters to activate downstream gene expression. The expression of clock genes like Period (Per1, Per2), Cryptochrome (CRY1, CRY2), and Rev-Erba is regulated through negative feedback mechanisms. In this loop, PER and CRY proteins inhibit the CLOCK–BMAL1 complex by forming a heterodimer and translocating to the nucleus. CRY1 primarily lengthens the circadian period through strong and stable repression of CLOCK/BMAL1 activity, while CRY2 shortens the period with weaker and more transient repression. CRY1 is more stable and peaks earlier in the circadian cycle, whereas CRY2 is less stable and peaks later. Their complementary roles ensure balance and precision in the circadian clock. Additionally, Rev-Erba and RORa can respectively inhibit and promote the transcription of Bmal1, constituting another negative feedback regulatory loop [18,19,20]. For a detailed overview of these processes, refer to Figure 1 and Table 1.
Circadian rhythms are vital in plants, governing key physiological processes necessary for growth, development, and environmental adaptation. The circadian clock in plants regulates daily rhythms in photosynthesis, flowering, and hormone signaling, aligning internal processes with the external light–dark cycle [21]. Central to the plant circadian system are several core components and regulatory circuits that mirror those in mammals but also exhibit unique features adapted to plant life. Key elements of the plant circadian clock are TOC1 (TIMING OF CAB EXPRESSION 1), LHY (LATE ELONGATED HYPOCOTYL), and CCA1 (CIRCADIAN CLOCK ASSOCIATED 1). These proteins form a transcriptional feedback loop that regulates the expression of various clock-controlled genes. The circuit begins with the LHY and CCA1 proteins activating the TOC1 gene, which, in turn, represses the expression of LHY and CCA1. This negative feedback loop generates rhythmic changes in gene expression that drive daily physiological processes [22].
While the study of circadian rhythms in plants provides valuable insights into basic biological processes, this review will focus primarily on circadian rhythms in mammals. This emphasis is due to the profound implications of circadian rhythms on human health, as disruptions to these rhythms are linked to a range of diseases.
1.3. Circadian Rhythm and Diseases
Proper circadian function is essential for maintaining health, as disruptions to this delicate balance can lead to a variety of diseases (Table 2). Misalignment between internal circadian rhythms and external factors, like shift work, irregular sleep, or jet lag, is associated with metabolic disorders, cardiovascular diseases, and mental health issues. Research has shown that such circadian disruptions can lead to chronic conditions like obesity, diabetes, hypertension, and mood disorders by altering key physiological processes [23]. Understanding the impact of circadian rhythms on disease is an emerging research focus. This section explores how circadian disruptions contribute to disease pathology and highlights potential strategies to restore circadian balance for better health outcomes.
1.3.1. Circadian Rhythm and Cancer
Circadian rhythm is closely associated with the occurrence of multiple cancers [24,25]. Environmental changes and hormonal disruptions can impair circadian rhythm genes, causing irregular cell cycles, inflammation, and carcinogenic signaling pathway activation, which heightens the risk of cancer cell proliferation and metastasis [26]. Irregular light exposure, including jet lag and shift work, is a potential risk factor for circadian disruption and cancer. Epidemiological studies indicate the association between circadian disruption and increased risk of specific types of cancer [27]. The breast cancer study revealed that disrupting the circadian rhythm markedly enhances cancer cell dissemination and lung metastasis in mice [28]. A study of 1900 Korean women identified a strong link between night shift work and a heightened risk of breast cancer, particularly among patients carrying the heterozygote genotype of CRY2 rs2292912 or RORA rs1482057 [29]. Research on melanoma model mice exposed to chronic jet lag or continuous light exposure showed that circadian rhythm disruption promoted tumor growth by regulating immune responses and cell cycle regulatory factors [30].
1.3.2. Circadian Rhythm and Metabolism
Circadian rhythm is crucial for maintaining metabolism, and mutation models of core clock genes reveal a close connection between circadian rhythm and metabolic dysregulation by perturbing immune responses and expression of cell cycle regulatory factors. Bmal1 deficiency leads to circadian rhythm disruption, as well as weight gain, increased adipose tissue weight, and enlarged adipocytes, while also lowering the circulating levels of polyunsaturated fatty acids (PUFAs) [31]. Further research has found that pancreatic-specific Bmal1 mutant mice showed impaired glucose tolerance and insulin secretion, along with elevated triglycerides and cholesterol levels, resulting in diabetes [32]. Per2- and CRY-deficient mice show alterations in lipid metabolism and gluconeogenesis [33,34]. Additionally, sleep disruption can lead to physiological and psychological stress, impair gut microbiota, and cause inflammation and metabolic diseases [35]. Studies have found that dysbiosis of gut microbiota in mice with disrupted circadian rhythms is affected by jet lag [36,37]. In summary, adjusting sleep and dietary patterns may be an effective approach to improving metabolic conditions.
1.3.3. Circadian Rhythm and Neurodegenerative Diseases
Neurodegenerative diseases are closely related to circadian rhythms. Studies suggested that circadian disruption could be a risk factor for Alzheimer’s disease (AD) and Parkinson’s disease (PD), refer to Table 2. It was found that some circadian-related genes may be potential risk genes for AD. Changes in the rhythmic expression of Bace2 and ApoE in the hippocampus of aged AD mouse models revealed circadian rhythms could impact AD [38]. Another survey study of 13 patients with AD found that they had longer resting intervals during the day, more frequent napping, and atypical circadian rhythms of melatonin release [39]. Research on patients with PD in China found that clock gene polymorphisms and circadian rhythm disruption were associated with the risk of PD [40]. These studies indicate that disrupting circadian rhythms may influence the development of neurodegenerative diseases.
1.3.4. Circadian Rhythm and Neurodevelopmental Disorders
Circadian rhythm disruption is closely associated with neurodevelopmental disorders and sleep disturbances [41]. Autism spectrum disorder (ASD) shows a particularly significant relationship with circadian rhythm disruption, with up to 83% of patients with ASD exhibiting disruptions in sleep rhythms, leading ASD to be considered as a sleep disorder [42]. Recent research highlights notable disparities in sleep quality and circadian rhythm markers between adults with ASD experiencing sleep issues and healthy adults [43]. Research on monozygotic twins identified genetic and epigenetic factors in ASD, highlighting notable differences in gene methylation levels, especially increased methylation in the RORα gene promoter region in individuals with ASD compared to their healthy twin [44]. Related studies further emphasized the role of RORα in the occurrence of ASD and found that the RORα agonist SR1078 is associated with behavioral changes in ASD animal models [45]. A study identified significant associations between the circadian rhythm genes PER1, NPAS2, and ASD [46]. Research on circadian rhythm gene mutations has identified specific genetic alterations linked to ASD. In this study, 28 patients with ASD (14 with sleep disorders and 14 without) and 23 control subjects of Japanese descent were analyzed. These findings provide new clues for a deeper understanding of the pathogenesis of ASD [47]. These findings enhance comprehension of circadian rhythm regulation in neurodevelopmental disorders.
1.3.5. Circadian Rhythm and Musculoskeletal Disorders
The circadian clock plays a crucial role in musculoskeletal health, with important implications for osteoarthritis (OA) and osteoporosis. Research indicates that circadian rhythm disruptions contribute to cartilage degeneration and OA pathology, with patients with OA showing circadian patterns in symptoms such as pain and stiffness, suggesting a link between circadian rhythms and joint health [48]. OA cartilage exhibits higher PER2 mRNA levels and reduced BMAL1 expression compared to healthy cartilage, indicating intrinsic circadian clock disruption in chondrocytes and associated increased MMP13 transcription and altered matrix composition [49]. Similarly, the dysregulation of circadian rhythm pathways in OA affects core clock genes and their networks, exacerbated by environmental factors like shift work, which worsen cartilage degradation in murine models [50]. In bone metabolism, disrupting Cry and Per genes in mouse osteoblasts increases bone mass, emphasizing circadian genes’ role in bone biology [51]. BMAL1, a central clock gene, regulates bone resorption and mass through osteoclast differentiation pathways. BMAL1 knockout mice exhibit elevated RANKL expression and osteoclast levels, leading to increased bone resorption [54], whereas BMAL1 overexpression reduces bone loss by modulating NFATc1 signaling [57]. Moreover, Per2 and Cry2 knockout studies highlight their roles in osteoblast and osteoclast functions, respectively, influencing bone formation rates and structure [52,53]. BMAL1 deficiency also impairs bone density and marrow differentiation, indicating its crucial role in maintaining bone integrity [55,56]. Therapeutic strategies targeting circadian mechanisms could offer new approaches for managing OA, osteoporosis, and other musculoskeletal disorders.
1.3.6. Circadian Rhythm and Cardiovascular Disorders (CVDs)
Circadian rhythms are crucial for cardiovascular health, and their disruptions are associated with negative impacts on heart function and disease progression [58]. Genetic mutations in clock genes such as Bmal1, Clock, and Npas2 in mouse models have been shown to lower mean arterial pressure and impair sympathoadrenal responses to stress, indicating their essential role in cardiovascular regulation [59]. Specifically, cardiomyocyte-specific Bmal1 knockout results in impaired glucose utilization, accelerated dilated cardiomyopathy, and decreased longevity, underscoring the gene’s significance in cardiac health [60]. Additionally, disruptions in clock genes influence the expression of insulin signaling components in cardiac tissues, highlighting the link between metabolic and cardiovascular regulation [61]. Studies involving light/dark cycle manipulations, circadian period mutations, and SCN lesions have consistently demonstrated the profound impact of circadian disruptions on cardiovascular and immune functions, mirroring human data on circadian misalignment [62]. Intrinsic circadian regulation is evident in the heart, as core clock component oscillations have been observed in rodent and human tissues, as well as in cultured cardiomyocytes [63]. Cardiomyocyte-specific Clock-mutant mice, which maintain an unaffected central circadian system, exhibit disrupted heart rate rhythms and significant reductions in heart rate compared to wild-type mice [12]. These studies indicate that the cardiomyocyte circadian clock governs crucial heart functions, such as non-oxidative fatty acid and glucose metabolism, fatty acid responsiveness, contractility, and overall cardiac performance [63]. In summary, the circadian clock is integral to regulating heart rate, metabolism, signal responsiveness, contractility, and cardiac growth and regeneration, with disruptions in these rhythms contributing to cardiovascular disease (Table 2).
1.4. Transcriptional Regulatory Basis of Circadian Rhythms
The regulation of the mammalian biological clock involves not only the core regulatory loop (Figure 1) but also various transcription factors that modulate the core loop, as well as different types of modifications [8,64]. Transcription factors contain core transcription factors such as BMAL1, CLOCK, PER, and CRY; acidic amino acid transcription factors such as DBP, TEF, and HLF; and basic leucine zipper (bZIP) transcription factors such as NFIL3/E4BP4. Circadian transcription factors control the pacing and regulation of the oscillators as well as the downstream outputs, which are governed by complex feedback loops and post-translational modifications [65,66]. These factors promote transcription by recognizing D-box sequences on promoters and enhancers through competitive binding. NFIL3 also has a function of transcriptional repression. Core transcription factors and NFIL3 display antiphase activities, leading to diurnal expression patterns of their target molecules, like RORγ, that are inversely related. The peak expression of RORγ, occurring when REV-ERBa expression is at its lowest, enhances the transcriptional expression of BMAL1 [67]. This interaction is equally crucial for regulating circadian rhythms. The phosphorylation of BMAL1 and CLOCK influences their activity and stability, thereby impacting the circadian rhythm [65]. PER and CRY proteins undergo phosphorylation by casein kinase 1 (CK1), which is important for their degradation and the rhythmic timing of the negative feedback loop [68].
In addition, multiple clock transcription factors have been found to share common binding sites on clock genes, indicating the existence of cooperative regulation by multiple clock transcription factors. Core transcription factors do not drive all core clock genes. Recent studies discovered a new circadian transcription factor, CHRONO, which exhibited circadian expression and inhibited Bmal1 target genes by interacting with BMAL1–CLOCK and PER proteins [69,70,71]. Genome-wide studies have also revealed the widespread presence of post-transcriptional regulation, and most rhythmically expressed mRNA transcription molecules themselves do not have potential transcription rhythms. This means that, although many mRNA molecules are expressed rhythmically (i.e., their expression levels fluctuate in a 24 h cycle), their transcription process does not show a clear rhythmic pattern. Instead, the regulation of mRNA stability and degradation may play a crucial role in the circadian regulation mechanism [72,73,74,75,76]. mRNA processing elements like polyadenylation, histone modifications, and chromatin remodeling also influence the daily patterns of transcript accumulation and degradation [77,78].
Recent studies indicate that in complex systems, RNA Pol II is loaded onto promoters to initiate gene transcription, alongside active marks like H3K4me3 and H3K27Ac [79,80]. The reoccupation of these sites by PER1/2 and CRY2 transitions the process from promotion to inhibition, with subsequent delayed binding of CRY1 finalizing the loop reset (Figure 1). This review primarily focuses on histone modifications, chromatin remodeling, and Pol II pausing control outside the core transcription factors of circadian rhythms (Figure 2).
2. Circadian Rhythm and Histone Modifications
2.1. Histone Methylation
While DNA methylation levels in promoters show little variation over the circadian cycle, other epigenetic modifications, particularly histone methylation, exhibit dynamic oscillations that are tightly coupled with transcriptional rhythms [81]. Circadian rhythm genes directly influence histone modification regulatory factors, which reciprocally interact with the circadian rhythm, establishing a mutual regulatory mechanism [82,83,84]. Histone methylation is controlled by numerous histone methyltransferases (HMTs) and demethylases [85]. Histone methylation can correlate with transcription factor (TF) activity or inactivity. Histone basic residues can undergo mono-, di-, or trimethylation, each influencing transcription distinctly. Histone H3 lysine 4 trimethylation (H3K4me3) correlates with active promoters, whereas H3K4me1 is linked to enhancers [86,87,88]. H3K27me3, catalyzed by polycomb repressive complexes 2 (PRC2), acts as a repressive mark by serving as a scaffold for heterochromatin protein 1 (HP1), which induces nucleosome condensation and promotes a compact, transcriptionally silent heterochromatin state [89,90]. For example, PER facilitates the recruitment of the HP1γ–Suv39h HMT complex, which catalyzes the dimethylation and trimethylation of unmodified H3K9 residues, thereby promoting local chromatin repression [91].
2.2. Histone Acetylation
Histone acetylation is regulated by the interaction between histone acetyltransferases (HATs) and histone deacetylases (HDACs). Histone H3 acetylation at lysines 9 and 27 (H3K9ac and H3K27ac) enhances transcription factor binding, thereby activating transcription and increasing chromatin accessibility chromatin accessibility [92,93]. The bromodomain and extra-terminal (BET) protein family recognizes histone acetylation and is involved in transcription processes, including nucleosome remodeling and the recruitment of elongation factors [94,95]. Nuclear receptor corepressors (NCORs) interact with a range of factors mediating transcriptional repression, including HDAC3 [96]. HDAC3 recognizes the deacetylase-activating domain (DAD) of highly conserved NCOR1/2, which is essential for HDAC3 catalytic activity [97,98,99]. REV-ERBs recruit NCOR and HDAC3, collectively promoting histone deacetylation and repression of clock genes [100,101,102]. Subsequent studies indicated that deleting NCOR1 or HDAC3 specifically in the liver suppressed the expression of BMAL1 [100,101,103]. Additionally, mice with point mutations in the DAD of NCOR1 and SMRT (NS-DADm) show diminished HDAC3 recruitment and deacetylase activity, leading to altered clock gene expression and circadian behavior disruptions [104,105].
The intracellular redox state of NAD+/NADH also influences the circadian rhythm. The reduced forms of NAD(H) and NADP(H) can enhance DNA binding by directly binding to the BMAL1/CLOCK and NPAS2 heterodimers. Conversely, the oxidized variants, NAD+ and NADP+, mitigate this impact [106]. NAD+ acts as a cofactor for SIRT1, which rhythmically binds to CLOCK–BMAL1 and deacetylates PER2 and BMAL1 [107,108]. Deacetylation enhances PER2 degradation and reverses CLOCK-mediated acetylation of BMAL1, facilitating its interaction with CRY1 [108,109]. Interestingly, HDAC3 interacts with nuclear membrane proteins and the transcriptional repressor LAP2β independently of its deacetylase activity, anchoring chromatin to specific locations and inhibiting transcription [110,111,112]. NAD+ oscillations regulate SIRT1’s daily activity, forming a metabolic feedback loop linked to circadian transcriptional mechanisms. Additionally, AMP-dependent protein kinase (AMPK) increases the intracellular NAD+/NADH ratio during fasting, which activates SIRT1 to deacetylate and enhance the transcriptional activity of PGC1α [113,114]. Intracellular glucose can affect the activity of clock TFs through O-GlcNAcylation, while PER inhibits phosphorylation and enhances its own inhibitory activity through O-GlcNAcylation catalyzed by serine residues via O-GlcNAc transferase [115,116]. Furthermore, BMAL1 and CLOCK undergo rhythmic O-GlcNAcylation, which enhances the transcriptional activity of this heterodimer by competitively inhibiting its ubiquitin-mediated degradation [117].
2.3. Histone Phosphorylation
In mammals, the core transcriptional loop of the circadian rhythm triggers the expression of PER and CRY, which form heterodimers in the cytoplasm and are transported to the nucleus following phosphorylation by casein kinase I [10,68,118,119]. In the nucleus, the BMAL–CLOCK heterodimer interacts with lysine-specific demethylase 1 (LSD1) and JARID1A. Protein kinase Cα phosphorylates LSD1, enhancing its interaction with BMAL1–CLOCK to activate transcription [120]. Furthermore, phosphorylation processes, essential for metabolic homeostasis, regulate the circadian rhythm, with numerous phosphorylation pathways exhibiting feedback mechanisms to modulate this rhythm. Clock transcription factors can directly engage with metabolic pathway signaling elements, such as AMP-activated protein kinase (AMPK), a key regulator of metabolic signaling [121,122]. During fasting, AMPK is phosphorylated and activated by upstream signals, increasing the ratio of AMP to ATP [123]. Activated AMPK phosphorylates numerous proteins, including CRY1 in the liver. Phosphorylation of CRY1 leads to protein inactivation, degradation, and phase shifts in rhythmic expression in the liver [124]. AMPK also phosphorylates and degrades PER2 to regulate peripheral clocks by activating casein kinase I [125].
2.4. Histone Adenylation and Ubiquitination
Polyadenylation can influence the daily patterns of transcript accumulation and degradation [77,78,126]. Additionally, ubiquitination also influences the circadian rhythm loop. The reduction in CRY1 levels, which may activate loop transcription, could result from degradation facilitated by the E3 ubiquitin ligase FBXL3 [127,128,129,130]. These studies highlight the complex epigenetic regulation of circadian rhythms, detailing the interactions between clock transcription factors and co-regulatory elements and clarifying the roles of histone modifications and their epigenetic regulators in transcriptional processes. Some epigenetic regulatory factors may not necessarily require catalytic activity, challenging the concept of direct effects of histone modifications on transcriptional regulation, thus warranting further investigation [131,132,133]. Additionally, while an increasing number of histone modifications are being identified, their biological significance and transcriptional functions remain to be validated [134]. Therefore, it is imperative to elucidate the coordinated interactions, catalytic dependency, and independent functions of epigenetic regulatory factors in circadian transcriptional regulation.
2.5. Histone Sumoylation and Redox Modifications
Sumoylation, a post-translational modification, involves attaching small ubiquitin-like modifier (SUMO) proteins to target proteins, affecting their stability and function. SUMO modification of BMAL1 has been shown to affect its stability and transcriptional activity, thereby impacting the overall circadian rhythm [135,136]. Redox modifications, including cysteine residue oxidation, contribute to the regulation of circadian proteins [137]. The cellular redox state can affect CLOCK and BMAL1 activity, connecting circadian rhythms with metabolic and oxidative conditions [22,138].
3. Circadian Rhythm and Chromatin Remodeling
3.1. Chromatin Structure
In addition to histone remodeling, the circadian rhythm also regulates gene transcription rhythms by modulating chromatin structure. Nuclear architecture models suggest that chromosomes can form non-random aggregates, dynamically influencing metabolism, transcription processes, and development [139,140]. Therefore, changes in genome structure often occur in circadian rhythms. For example, chromatin conformation capture reveals rhythmic interactions between DBP and circadian loci on individual chromosomes, dependent on BMAL1 [141]. In mouse embryonic fibroblasts, PARP1 and CTCF regulate circadian rhythms by relocating clock-controlled genes (CCGs) to lamina-associated domains (LADs) [142]. Consistently, histone H3 lysine 9 methylation 2/3 (H3K9me2/3) consistently emerges as a crucial element in the repositioning of rhythmic genes to LADs [142]. Enhancer–promoter domains facilitated by cohesion are nested within larger CTCF–Cohesin domains [143]. Rev-erba suppresses Bmal1 expression by recruiting nuclear receptor co-repressor (NCoR) and HDAC3 to suppress downstream expression [144]. These findings indicate that circadian rhythms regulate chromatin structure, with dynamic enhancer–promoter loop changes influencing the rhythmic expression of CCGs and potentially affecting various metabolic processes [145]. This raises crucial questions for future research, such as how rhythm-dependent chromatin structures and their dynamic changes affect cellular metabolic states.
3.2. Chromatin State
Chromatin, a DNA–protein complex, packages DNA within the cell nucleus, primarily arranged in repetitive arrays known as typical nucleosomes [146,147]. Translational modifications of chromatin serve as signaling factors regulating the accessibility or compaction of genomic elements. Simultaneously, accessibility or compaction is regulated by combinations of acetylation, phosphorylation, methylation, and ubiquitination, which can reshape chromatin states [148,149,150,151,152,153,154,155]. For example, from yeast to mammals, the conserved chromatin mechanism regulated by circadian rhythmicity (CRFH) forms and rhythmic molecules involving deacetylation, H3K9me, and HP1 binding engage in feedback inhibition.
The rhythmic post-translational modifications of chromatin can be explained by ATP-dependent remodeling enzymes and their equivalents. However, the specific modifications requiring remodeling enzymes lack a research foundation. ATP-dependent remodeling enzymes include conserved remodelers such as SWI/SNF (SWItch/sucrose nonfermentable) and the CHD family (CHD3/CHD4), both of which are necessary for the expression of circadian rhythm genes. In Neurospora crassa, the interaction between SWI/SNF and White Collar Complex (WCC) is necessary for the expression of the circadian gene FRQ (Frequency) [156]. Brahma (Brm), as the SWI/SNF complex in fruit flies, modifies the chromatin state of dper and tim to restrict Pol II recruitment. In mammals, the SWI/SNF subunit BAF60a plays a crucial role in liver circadian rhythms and is vital for energy metabolism [157]. Based on systematic studies, the SWI/SNF complex can alter the chromatin around transcription start sites to regulate the accessibility of Pol II and transcription factors [156,158]. Additionally, enhancer-associated lncRNAs, like lncCrot, play a role in regulating distal circadian enhancer interactions to enhance CCG expression [159]. However, the mechanisms by which lncRNAs, such as Per2AS, and eRNAs modify chromatin states to influence circadian rhythms remain unexplored and extend beyond the existing circadian regulation model.
3.3. Nucleosome Changes
The nucleosome is the basic structural unit of chromatin, consisting of four types of histones. Nucleosomes regulate circadian transcription, possibly because clock transcription factors (TFs) require tissue-specific TFs to bind to enhancers. These tissue-specific TFs interact with closed chromatin, reducing local nucleosome density. For example, the nuclear PER complex guides histone H3 lysine 9 methyltransferase (SUV39H1) to promote deacetylation and recruitment of the Per1 and Per2 promoters, leading to rhythmic di- and trimethylation of histone H3 lysine 9 (H3K9) [91,160].
In mammals, 30% of enhancer RNA (eRNA) is regulated by circadian rhythms, which is associated with nucleosomes H3K27ac and H3K4me1 [161]. CHD3 and CHD4 function as auxiliary repressive elements in circadian rhythm regulation within the nucleosome remodeling and deacetylase (NuRD) complex [162,163]. In Neurospora crassa, CSW-1 deficiency disrupts negative feedback in the circadian rhythm loop, facilitating nucleosome relocation to c-boxes and hindering White Collar Complex (WCC) binding [164]. The clock ATPase (CATP) promotes FRQ expression through c-box nucleosomes [165]. Overall, the presence of numerous nucleosome removal-related factors in circadian genes suggests the involvement of nucleosomes in circadian rhythm regulation. However, how these factors interact with modified nucleosomes and their exact catalytic activities remain unknown.
4. Circadian Rhythm and Pol II Pausing Control
Rhythmic proteins and transcription factors typically regulate the rhythmic transcription of gene promoters as distal enhancers. These transcription factors must engage with intermediate complexes and other transcription factors near the transcription start site (TSS) to regulate transcription. The recruitment and pausing of Pol II have recently received attention in the circadian field [8,79,166,167]. Pol II pausing, influenced by Pol II recruitment, pause release, and premature transcription termination near the TSS, is crucial for transcriptional output. Transcription factors regulate Pol II transcription at the start site by interacting with general transcription factors (GTFs) on the gene promoter through intermediate complexes [168,169]. The subunits of Pol II that interact with clock protein complexes remain to be determined. Transcription factors and co-factors guide intermediate complexes to assemble pre-initiation complexes (PICs) at the TSS for transcription initiation and re-initiation [170]. TFs and distal enhancers bound to promoters are believed to approach through chromatin looping, facilitated by proteins such as Cohesin and CTCF [171]. Transcription bursting involves multiple Pol II initiation events in a short time, regulated by enhancer–promoter proximity and recruitment of transcription factors and mediators, with underlying mechanisms still being explored [172]. Single-cell imaging studies show that transcription of numerous genes, such as clock genes, occurs randomly and infrequently [173]. Transcription within cells alternates between active and inactive states, characterized by transcription bursts followed by extended inactivity periods [174]. Transcription bursting can be explained by the formation of transcriptional centers, where TFs, co-factors, mediators, and Pol II aggregate/molecularly condense, facilitating multiple rounds of RNA polymerase II initiation [175,176]. Transcription bursting necessitates pause release, exemplified by p-TEFb-licensed Pol II elongation, which overcomes the +1 nucleosome barrier to transcribe the gene [177,178]. Once Pol II is initiated, it remains active for only a short period before entering a paused state, where it is held downstream of the transcription start site (TSS) by pause factors (DSIF and NELF) and the +1 nucleosome [179]. p-TEFb is a component of the super elongation complex (SEC), which facilitates paused Pol II, enabling it to re-initiate and complete transcription bursting [180,181]. Initiated Pol II could prematurely transcription termination at the 5′ end of the gene, reducing Pol II pausing [182,183].
The recruitment, pausing release, and premature transcription termination activities of Pol II exhibit genome-wide variations, peaking at distinct circadian phases [79]. During pausing release, p-TEFb recruits the PAF1 complex (PAF1c) to activate SET1, leading to the deposition of H3K4me3 downstream of gene TTSs [184,185,186]. Early in the night, H3K4me3 increases genome-wide in mouse liver [187,188]. [Pol II]GB (Pol II signals in the gene body) shows more gene-specific changes throughout the day compared to [Pol II]TSS (Pol II recruitment) and [Tbp]TSS (Tbp signals within the transcription start site region) [126]. The bimodal distribution of gene transcription peaks aligns with the accumulation of pre-mRNA. Daily variations in the usage of [Tbp]TSS, [Pol II]TSS, and [Pol II]GB could be related to the cell cycle, given its known impact on transcription [189]. In particular, transcription is typically suppressed during mitosis and reactivated at the end of mitosis [190,191]. Daily fluctuations in cell cycle activity interact with the circadian rhythm [192,193]. CDK1 activity, essential for mitotic entry, shows daily variations influenced by the circadian clock and reciprocally modulates clock oscillations [194,195].
The recruitment of Pol II to the gene’s promoter does not directly influence transcription levels, challenging prevailing perspectives on Pol II recruitment regulation and transcriptional bursting [196]. However, this can be explained if pausing control is involved. If pausing release is necessary for transcriptional bursting and is independent of pre-initiation complex (PIC) regulation, then this paradox can be reconciled because transcriptional bursting occurs independently of PIC formation [197]. Recent research results indicate that when the mediator complex is rapidly degraded to restrict Pol II recruitment and initiation, there is a decrease in cell-type-specific gene transcription. Nevertheless, compensatory increases in pausing release help sustain the transcription of numerous other genes. These findings indicate that pausing release can affect transcription independently of Pol II recruitment (Figure 3 and Table 3).
5. Conclusions
This review investigates the transcriptional and epigenomic mechanisms through which circadian rhythm transcription factors control diurnal gene expression, highlighting the complexity of circadian rhythmicity in epigenetic regulation and questioning previous perspectives. We have discussed the new roles of chromatin structure, chromosome status, and nucleosome changes in circadian rhythm transcriptional regulation. These studies deepen our comprehension of circadian rhythm transcriptional architecture and inspire novel scientific questions and hypotheses. A major role of the circadian rhythm is to regulate chromatin state and structure, thereby influencing the timing and intensity of gene expression governed by circadian cycles. A conserved model incorporating deacetylation, H3K9me2/3, HP1 binding, and dynamic DNA methylation plays a crucial role in the negative feedback inhibition of circadian rhythms. Emerging connections between chromatin state changes and lncRNA are being identified. Finally, we have also highlighted the crucial role of Pol II pausing in circadian rhythm transcriptional output.
We highlighted how circadian rhythm transcription regulates metabolism through interacting mechanisms. Human genetics, epidemiology, and clinical research have associated circadian rhythm disruptions with various diseases and identified transcriptional regulatory mechanisms of circadian rhythms as fundamental for intervention studies. It further advances the molecular basis of circadian pathophysiology discovered at the systemic level. From transcriptional rhythms to circadian behavior, this will reveal more dimensions of the endogenous circadian rhythms of life on Earth. Circadian rhythm disruption has profound implications for human health, and in-depth research into the molecular mechanisms of circadian rhythm transcriptional regulation is crucial for identifying disease symptoms and mechanisms.
Although extensively studied, the exact mechanisms governing tissue-specific regulation of circadian rhythms are not yet fully understood. Distinct circadian gene expression patterns across tissues imply the existence of unknown regulatory elements and factors that contextually influence the core clock machinery. Understanding these tissue-specific regulatory networks is crucial for deciphering how circadian rhythms influence various physiological processes. The role of non-coding RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), in circadian regulation is gaining attention. Non-coding RNAs are crucial in modulating the expression of core clock genes and their downstream targets. The precise mechanisms through which non-coding RNAs affect circadian rhythms remain unclear, necessitating additional research to clarify their roles and regulatory networks.
Emerging evidence suggests a complex connection between circadian rhythms and metabolic processes, though the precise molecular mechanisms remain under investigation. For example, how do metabolic signals influence the core clock components, and conversely, how do circadian clocks regulate metabolic pathways? Exploring these questions may offer valuable insights for developing chronotherapy strategies for metabolic disorders. At the same time, while the influence of light–dark cycles on circadian rhythms is well established, the impact of other environmental and behavioral factors, such as diet, exercise, and social interactions, on circadian regulation is less well understood. Research in this area could identify novel external cues that modulate the circadian clock and uncover potential interventions for circadian-related disorders.
Addressing the questions mentioned above requires a multidisciplinary approach that combines molecular biology, genetics, bioinformatics, and systems biology. Advanced technologies like single-cell RNA sequencing, CRISPR gene editing, and high-resolution imaging are crucial for revealing the complexities of circadian regulation. Integrating circadian biology with neurobiology, endocrinology, and immunology offers a comprehensive understanding of the impact of circadian rhythms on health and disease. Collaborative efforts between researchers, clinicians, and industry will be essential to translate basic circadian research into therapeutic applications. Personalized chronotherapy, which considers an individual’s circadian profile, holds promise for optimizing treatment efficacy and minimizing side effects for various diseases. Advancements in circadian rhythm research will enable the development of new interventions and strategies to enhance human health and well-being.
W.M.: investigation and writing—original draft preparation; X.G.: writing—original draft preparation; Q.C.: writing—review and editing; J.-D.L.: supervision. All authors have read and agreed to the published version of the manuscript.
The authors declare that they have no competing interests.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Enlarge this image.Figure 1. Core circadian rhythm loop in mammals. (1) Cry and Per Pathway: This is the primary feedback mechanism for the circadian clock. CLOCK and BMAL1 (activators) initiate the transcription of Per and Cry genes. The PER and CRY proteins then accumulate, form complexes, and translocate to the nucleus, where they inhibit the activity of CLOCK and BMAL1, thus shutting down their own transcription. This feedback loop is crucial for maintaining a roughly 24 h cycle. (2) ROR and REV Pathway: This pathway modulates the expression of clock genes, particularly Bmal1. ROR proteins (activators) bind to ROR response elements in the Bmal1 gene promoter to enhance its expression, while REV-ERB proteins (repressors) bind to the same region to inhibit Bmal1 transcription. The balance between ROR and REV-ERB activity helps stabilize the circadian rhythm and fine-tune its timing.
Enlarge this image.Figure 2. Illustration of negative feedback regulation in the circadian clock. Three key processes regulating transcription of the core circadian rhythm loop genes: histone modifications, chromatin remodeling, and Pol II pausing control.
Enlarge this image.Figure 3. Transcriptional network involving core clock transcription factors and other regulators of the molecular clock. This figure illustrates the roles of key molecules in three primary transcriptional regulation pathways—histone modifications, chromatin remodeling, and RNA polymerase II pausing control. The core clock transcription factors interact with co-regulatory factors to orchestrate these pathways, influencing circadian rhythm regulation. Together, these processes establish a dynamic and coordinated regulation of circadian rhythms in mammals.
Expression and roles of BMAL1, CLOCK, PER, and CRY in circadian rhythms.
| Protein | Type | Role in Circadian Rhythm | Expression Locations | Conservation Across Species |
|---|---|---|---|---|
| BMAL1 | Transcription factor (bHLH) | Forms a complex with CLOCK to drive circadian gene expression | SCN, liver, heart, and peripheral tissues [ | Highly conserved across eukaryotes |
| CLOCK | Transcription factor (bHLH) | Forms a complex with BMAL1 to activate circadian genes | SCN, liver, brain, and peripheral tissues [ | Highly conserved across eukaryotes |
| PER | Transcription factor (bHLH) | Represses CLOCK–BMAL1 activity in the feedback loop | SCN, liver, and various peripheral tissues [ | Highly conserved from flies to mammals |
| CRY | Photoreceptor/Transcription factor | Binds PER to mediate degradation and regulate the feedback loop | SCN, retina, and peripheral tissues [ | Highly conserved from flies to mammals |
Clock mechanism disturbance and diseases.
| Method of Clock Disturbance | Effects | Type of Diseases | Data Sources | Impact | Refs |
|---|---|---|---|---|---|
| Environmental changes | Abnormal cell cycles, intracellular inflammation, activation of carcinogenic pathways | Multiple cancer | Human data | Whole-body | [ |
| Irregular light exposure | Increased cancer cell proliferation and metastasis | BC, melanoma | Human data and mouse models | Whole-body and cell-specific | [ |
| Shift work | Increased risk of breast cancer, particularly with certain genotypes | BC | Human data and mouse models | Whole-body | [ |
| Chronic jet lag | Promoted tumor growth by regulating immune responses and cell cycle regulatory factors | Melanoma | Mouse models | Cell-specific | [ |
| Bmal1 deficiency | Weight gain, increased adipose tissue weight, decreased glucose tolerance, reduced insulin secretion | Metabolic disorders, diabetes | Mouse models | Whole-body and cell-specific | [ |
| Per2 and CRY deficiency | Alterations in lipid metabolism and gluconeogenesis | Metabolic disorders | Mouse models | Whole-body and cell-specific | [ |
| Sleep disruption | Physiological and psychological stress, impaired gut microbiota, inflammation | Metabolic diseases | Mouse models | Whole-body | [ |
| Circadian-related gene alterations | Potential risk genes for AD, altered rhythmic expression of specific genes | AD | Human data and mouse models | Whole-body and cell-specific | [ |
| Clock gene polymorphisms | Associated with the risk of PD | PD | Human data | Whole-body | [ |
| Circadian rhythm disruption | Increased frequency of napping, atypical circadian rhythms of melatonin release | AD | Human data | Whole-body | [ |
| Circadian rhythm disruption | Significant disruptions in sleep rhythms, altered gene methylation levels | ASD | Human data and mouse models | Whole-body and cell-specific | [ |
| Circadian rhythm gene mutations | Specific gene mutations associated with ASD | ASD | Human data | Whole-body | [ |
| Intrinsic circadian clock disruption in chondrocytes | Increased MMP13 transcription, altered matrix composition | OA | Human data and mouse models | Whole-body and cell-specific | [ |
| Cry and Per gene disruption in osteoblasts/knockout | Increased bone mass/Influenced bone formation rates and structure | Osteoporosis | Mouse models | Whole-body | [ |
| BMAL1 knockout/deficiency | Elevated RANKL expression, increased bone resorption, impaired bone density/impaired bone density and marrow differentiation, maintained bone integrity | Osteoporosis | Mouse models | Whole-body | [ |
| BMAL1 overexpression | Reduced bone loss by modulating NFATc1 signaling | Osteoporosis | Mouse models | Whole-body | [ |
| Clock gene mutations | Lower mean arterial pressure, impaired sympathoadrenal responses to stress | CVD | Human data and mouse models | Whole-body | [ |
| Cardiomyocyte-specific BMAL1 knockout | Impaired glucose utilization, accelerated dilated cardiomyopathy, reduced longevity | CVD | Mouse models | Whole-body | [ |
| Light/dark cycle manipulations | Profound impact on cardiovascular and immune functions | CVD | Mouse models | Whole-body | [ |
| Circadian period mutations | Disrupted heart rate rhythms, reduced heart rate | CVD | Human data and mouse models | Whole-body and cell-specific | [ |
| SCN lesions | Mirrored human data on circadian misalignment effects | CVD | Human data and mouse models | Whole-body and cell-specific | [ |
Overview of mammalian circadian rhythm transcriptional regulation.
| Transcription Factors/Regulatory Genes | Description | Organisms Studied |
|---|---|---|
| CLOCK and BMAL1 | Form a heterodimer that binds to E-box elements, promoting expression of downstream genes like Per1, Per2, CRY1, CRY2, and Rev-Erba. | Mammals |
| PERs and CRYs | Form heterodimers and inhibit BMAL1 transcriptional activity. | Mammals |
| Rev-Erba | Inhibits the transcription of Bmal1. | Mammals |
| RORa | Promotes the transcription of Bmal1. | Mammals |
| DBP, TEF, HLF | Acidic amino acid and basic leucine zipper transcription factors that recognize D-box sequences on promoters and enhancers. | Mammals |
| NFIL3/E4BP4 | Recognizes D-box sequences and functions as a transcriptional repressor. | Mammals |
| CHRONO | Inhibits Bmal1 target genes by interacting with BMAL1–CLOCK and PER proteins. | Mammals |
| HMTs | Catalyze the methylation of histones, associated with transcriptional activation or repression. | Mammals |
| Histone demethylases | Remove methyl groups from histones, affecting transcriptional regulation. | Mammals |
| H3K4me3, H3K4me1 | Marks associated with active promoters and enhancers, respectively. | Mammals |
| H3K27me3 | A repressive mark catalyzed by PRC2, associated with transcriptional repression. | Mammals |
| H3K9me2/3 | Associated with the repression of the chromatin state. | Mammals |
| HATs | Catalyze the acetylation of histones, promoting transcription and chromatin accessibility. | Mammals |
| HDACs | Removal of acetyl groups from histones leads to chromatin condensation and transcriptional repression. | Mammals |
| SIRT1 | Deacetylates PER2 and BMAL1, influencing circadian rhythm. | Mammals |
| AMPK | Phosphorylates CRY1 and PER2, affecting their stability and activity. | Mammals |
| Pol II | Involved in transcription initiation, pausing, and elongation. | Mammals |
| SWI/SNF, CHD family | ATP-dependent chromatin remodeling enzymes are essential for circadian gene expression. | Mammals, Neurospora crassa, fruit flies |
| CTCF | Mediates chromatin interactions and regulation. | Mammals |
| PARP1 | Mediates circadian regulation of chromatin by mobilizing clock-controlled genes to LADs. | Mammals |
| LncRNAs | Involved in regulating the interaction of distal enhancers to promote circadian gene expression. | Mammals |
| eRNAs | Enhancer RNAs involved in circadian regulation. | Mammals |
| Nuclear PER complex | Guides H3K9 methyltransferase to promote deacetylation and recruitment of Per1 and Per2 promoters. | Mammals |
| E3 ubiquitin ligase (FBXL3) | Mediates degradation of CRY1, influencing circadian loop activation. | Mammals |
References
1. Rosbash, M. The implications of multiple circadian clock origins. PLoS Biol.; 2009; 7, e62. [DOI: https://dx.doi.org/10.1371/journal.pbio.1000062] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19296723]
2. Pittendrigh, C.S. Temporal organization: Reflections of a Darwinian clock-watcher. Annu. Rev. Physiol.; 1993; 55, pp. 16-54. [DOI: https://dx.doi.org/10.1146/annurev.ph.55.030193.000313] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8466172]
3. Konopka, R.J.; Benzer, S. Clock mutants of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA; 1971; 68, pp. 2112-2116. [DOI: https://dx.doi.org/10.1073/pnas.68.9.2112]
4. Bargiello, T.A.; Young, M.W. Molecular genetics of a biological clock in Drosophila. Proc. Natl. Acad. Sci. USA; 1984; 81, pp. 2142-2146. [DOI: https://dx.doi.org/10.1073/pnas.81.7.2142]
5. Bargiello, T.A.; Jackson, F.R.; Young, M.W. Restoration of circadian behavioural rhythms by gene transfer in Drosophila. Nature; 1984; 312, pp. 752-754. [DOI: https://dx.doi.org/10.1038/312752a0]
6. Reddy, P.; Zehring, W.A.; Wheeler, D.A.; Pirrotta, V.; Hadfield, C.; Hall, J.C.; Rosbash, M. Molecular analysis of the period locus in Drosophila melanogaster and identification of a transcript involved in biological rhythms. Cell; 1984; 38, pp. 701-710. [DOI: https://dx.doi.org/10.1016/0092-8674(84)90265-4]
7. Zehring, W.A.; Wheeler, D.A.; Reddy, P.; Konopka, R.J.; Kyriacou, C.P.; Rosbash, M.; Hall, J.C. P-element transformation with period locus DNA restores rhythmicity to mutant, arrhythmic Drosophila melanogaster. Cell; 1984; 39, pp. 369-376. [DOI: https://dx.doi.org/10.1016/0092-8674(84)90015-1] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6094014]
8. Takahashi, J.S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet.; 2017; 18, pp. 164-179. [DOI: https://dx.doi.org/10.1038/nrg.2016.150]
9. Partch, C.L.; Green, C.B.; Takahashi, J.S. Molecular architecture of the mammalian circadian clock. Trends Cell Biol.; 2014; 24, pp. 90-99. [DOI: https://dx.doi.org/10.1016/j.tcb.2013.07.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23916625]
10. Aryal, R.P.; Kwak, P.B.; Tamayo, A.G.; Gebert, M.; Chiu, P.L.; Walz, T.; Weitz, C.J. Macromolecular Assemblies of the Mammalian Circadian Clock. Mol. Cell; 2017; 67, pp. 770-782.e6. [DOI: https://dx.doi.org/10.1016/j.molcel.2017.07.017] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28886335]
11. Hardin, P.E.; Panda, S. Circadian timekeeping and output mechanisms in animals. Curr. Opin. Neurobiol.; 2013; 23, pp. 724-731. [DOI: https://dx.doi.org/10.1016/j.conb.2013.02.018]
12. Bray, M.S.; Shaw, C.A.; Moore, M.W.; Garcia, R.A.; Zanquetta, M.M.; Durgan, D.J.; Jeong, W.J.; Tsai, J.Y.; Bugger, H.; Zhang, D. et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am. J. Physiol. Heart Circ. Physiol.; 2008; 294, pp. H1036-H1047. [DOI: https://dx.doi.org/10.1152/ajpheart.01291.2007]
13. Zheng, X.; Sehgal, A. Speed control: Cogs and gears that drive the circadian clock. Trends Neurosci.; 2012; 35, pp. 574-585. [DOI: https://dx.doi.org/10.1016/j.tins.2012.05.007]
14. Vitaterna, M.H.; Selby, C.P.; Todo, T.; Niwa, H.; Thompson, C.; Fruechte, E.M.; Hitomi, K.; Thresher, R.J.; Ishikawa, T.; Miyazaki, J. et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc. Natl. Acad. Sci. USA; 1999; 96, pp. 12114-12119. [DOI: https://dx.doi.org/10.1073/pnas.96.21.12114] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10518585]
15. Ko, C.H.; Takahashi, J.S. Molecular components of the mammalian circadian clock. Hum. Mol. Genet.; 2006; 15, pp. R271-R277. [DOI: https://dx.doi.org/10.1093/hmg/ddl207] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16987893]
16. Todd, W.D.; Venner, A.; Anaclet, C.; Broadhurst, R.Y.; De Luca, R.; Bandaru, S.S.; Issokson, L.; Hablitz, L.M.; Cravetchi, O.; Arrigoni, E. et al. Suprachiasmatic VIP neurons are required for normal circadian rhythmicity and comprised of molecularly distinct subpopulations. Nat. Commun.; 2020; 11, 4410. [DOI: https://dx.doi.org/10.1038/s41467-020-17197-2]
17. Preitner, N.; Damiola, F.; Lopez-Molina, L.; Zakany, J.; Duboule, D.; Albrecht, U.; Schibler, U. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell; 2002; 110, pp. 251-260. [DOI: https://dx.doi.org/10.1016/S0092-8674(02)00825-5] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12150932]
18. Sato, T.K.; Panda, S.; Miraglia, L.J.; Reyes, T.M.; Rudic, R.D.; McNamara, P.; Naik, K.A.; FitzGerald, G.A.; Kay, S.A.; Hogenesch, J.B. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron; 2004; 43, pp. 527-537. [DOI: https://dx.doi.org/10.1016/j.neuron.2004.07.018]
19. Hirano, A.; Fu, Y.H.; Ptáček, L.J. The intricate dance of post-translational modifications in the rhythm of life. Nat. Struct. Mol. Biol.; 2016; 23, pp. 1053-1060. [DOI: https://dx.doi.org/10.1038/nsmb.3326]
20. Yin, L.; Wang, J.; Klein, P.S.; Lazar, M.A. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science; 2006; 311, pp. 1002-1005. [DOI: https://dx.doi.org/10.1126/science.1121613]
21. Xu, X.; Yuan, L.; Yang, X.; Zhang, X.; Wang, L.; Xie, Q. Circadian clock in plants: Linking timing to fitness. J. Integr. Plant Biol.; 2022; 64, pp. 792-811. [DOI: https://dx.doi.org/10.1111/jipb.13230] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35088570]
22. Mezhnina, V.; Ebeigbe, O.P.; Poe, A.; Kondratov, R.V. Circadian Control of Mitochondria in Reactive Oxygen Species Homeostasis. Antioxid. Redox Signal.; 2022; 37, pp. 647-663. [DOI: https://dx.doi.org/10.1089/ars.2021.0274] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35072523]
23. Panda, S. Circadian physiology of metabolism. Science; 2016; 354, pp. 1008-1015. [DOI: https://dx.doi.org/10.1126/science.aah4967] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27885007]
24. Barbosa Vieira, T.K.; Jurema da Rocha Leão, M.; Pereira, L.X.; Alves da Silva, L.C.; Pereira da Paz, B.B.; Santos Ferreira, R.J.; Feitoza, C.C.; Fernandes Duarte, A.K.; Barros Ferreira Rodrigues, A.K.; Cavalcanti de Queiroz, A. et al. Correlation between circadian rhythm related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data. Mol. Cell Endocrinol.; 2021; 526, 111214. [DOI: https://dx.doi.org/10.1016/j.mce.2021.111214] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33610641]
25. Hu, H.; Chen, Z.; Ji, L.; Wang, Y.; Yang, M.; Lai, R.; Zhong, Y.; Zhang, X.; Wang, L. ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer. Cancer Lett.; 2020; 492, pp. 162-173. [DOI: https://dx.doi.org/10.1016/j.canlet.2020.08.034]
26. Albuquerque, T.; Neves, A.R.; Quintela, T.; Costa, D. Exploring the link between chronobiology and drug delivery: Effects on cancer therapy. J. Mol. Med.; 2021; 99, pp. 1349-1371. [DOI: https://dx.doi.org/10.1007/s00109-021-02106-x]
27. Lee, Y. Roles of circadian clocks in cancer pathogenesis and treatment. Exp. Mol. Med.; 2021; 53, pp. 1529-1538. [DOI: https://dx.doi.org/10.1038/s12276-021-00681-0]
28. Hadadi, E.; Taylor, W.; Li, X.M.; Aslan, Y.; Villote, M.; Rivière, J.; Duvallet, G.; Auriau, C.; Dulong, S.; Raymond-Letron, I. et al. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat. Commun.; 2020; 11, 3193. [DOI: https://dx.doi.org/10.1038/s41467-020-16890-6]
29. Pham, T.T.; Lee, E.S.; Kong, S.Y.; Kim, J.; Kim, S.Y.; Joo, J.; Yoon, K.A.; Park, B. Night-shift work, circadian and melatonin pathway related genes and their interaction on breast cancer risk: Evidence from a case-control study in Korean women. Sci. Rep.; 2019; 9, 10982. [DOI: https://dx.doi.org/10.1038/s41598-019-47480-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31358835]
30. Aiello, I.; Fedele, M.L.M.; Román, F.; Marpegan, L.; Caldart, C.; Chiesa, J.J.; Golombek, D.A.; Finkielstein, C.V.; Paladino, N. Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation. Sci. Adv.; 2020; 6, eaaz4530. [DOI: https://dx.doi.org/10.1126/sciadv.aaz4530]
31. Paschos, G.K.; Ibrahim, S.; Song, W.L.; Kunieda, T.; Grant, G.; Reyes, T.M.; Bradfield, C.A.; Vaughan, C.H.; Eiden, M.; Masoodi, M. et al. Obesity in mice with adipocyte-specific deletion of clock component Arntl. Nat. Med.; 2012; 18, pp. 1768-1777. [DOI: https://dx.doi.org/10.1038/nm.2979] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23142819]
32. Marcheva, B.; Ramsey, K.M.; Buhr, E.D.; Kobayashi, Y.; Su, H.; Ko, C.H.; Ivanova, G.; Omura, C.; Mo, S.; Vitaterna, M.H. et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature; 2010; 466, pp. 627-631. [DOI: https://dx.doi.org/10.1038/nature09253]
33. Grimaldi, B.; Bellet, M.M.; Katada, S.; Astarita, G.; Hirayama, J.; Amin, R.H.; Granneman, J.G.; Piomelli, D.; Leff, T.; Sassone-Corsi, P. PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab.; 2010; 12, pp. 509-520. [DOI: https://dx.doi.org/10.1016/j.cmet.2010.10.005]
34. Zhang, E.E.; Liu, Y.; Dentin, R.; Pongsawakul, P.Y.; Liu, A.C.; Hirota, T.; Nusinow, D.A.; Sun, X.; Landais, S.; Kodama, Y. et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat. Med.; 2010; 16, pp. 1152-1156. [DOI: https://dx.doi.org/10.1038/nm.2214] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20852621]
35. Reynolds, A.C.; Paterson, J.L.; Ferguson, S.A.; Stanley, D.; Wright, K.P., Jr.; Dawson, D. The shift work and health research agenda: Considering changes in gut microbiota as a pathway linking shift work, sleep loss and circadian misalignment, and metabolic disease. Sleep. Med. Rev.; 2017; 34, pp. 3-9. [DOI: https://dx.doi.org/10.1016/j.smrv.2016.06.009]
36. Thaiss, C.A.; Zeevi, D.; Levy, M.; Zilberman-Schapira, G.; Suez, J.; Tengeler, A.C.; Abramson, L.; Katz, M.N.; Korem, T.; Zmora, N. et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell; 2014; 159, pp. 514-529. [DOI: https://dx.doi.org/10.1016/j.cell.2014.09.048]
37. Voigt, R.M.; Summa, K.C.; Forsyth, C.B.; Green, S.J.; Engen, P.; Naqib, A.; Vitaterna, M.H.; Turek, F.W.; Keshavarzian, A. The Circadian Clock Mutation Promotes Intestinal Dysbiosis. Alcohol. Clin. Exp. Res.; 2016; 40, pp. 335-347. [DOI: https://dx.doi.org/10.1111/acer.12943]
38. Ma, Z.; Jiang, W.; Zhang, E.E. Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer’s disease-risk genes. Sci. Rep.; 2016; 6, 36035. [DOI: https://dx.doi.org/10.1038/srep36035] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27796320]
39. Weissová, K.; Bartoš, A.; Sládek, M.; Nováková, M.; Sumová, A. Moderate Changes in the Circadian System of Alzheimer’s Disease Patients Detected in Their Home Environment. PLoS ONE; 2016; 11, e0146200. [DOI: https://dx.doi.org/10.1371/journal.pone.0146200]
40. Gu, Z.; Wang, B.; Zhang, Y.B.; Ding, H.; Zhang, Y.; Yu, J.; Gu, M.; Chan, P.; Cai, Y. Association of ARNTL and PER1 genes with Parkinson’s disease: A case-control study of Han Chinese. Sci. Rep.; 2015; 5, 15891. [DOI: https://dx.doi.org/10.1038/srep15891]
41. Benedict, C.; Blennow, K.; Zetterberg, H.; Cedernaes, J. Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men. Neurology; 2020; 94, pp. e1181-e1189. [DOI: https://dx.doi.org/10.1212/WNL.0000000000008866] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31915189]
42. Ballester, P.; Richdale, A.L.; Baker, E.K.; Peiró, A.M. Sleep in autism: A biomolecular approach to aetiology and treatment. Sleep. Med. Rev.; 2020; 54, 101357. [DOI: https://dx.doi.org/10.1016/j.smrv.2020.101357] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32759030]
43. Ballester, P.; Martínez, M.J.; Javaloyes, A.; Inda, M.D.; Fernández, N.; Gázquez, P.; Aguilar, V.; Pérez, A.; Hernández, L.; Richdale, A.L. et al. Sleep problems in adults with autism spectrum disorder and intellectual disability. Autism Res.; 2019; 12, pp. 66-79. [DOI: https://dx.doi.org/10.1002/aur.2000] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30273974]
44. Nguyen, A.; Rauch, T.A.; Pfeifer, G.P.; Hu, V.W. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J.; 2010; 24, pp. 3036-3051. [DOI: https://dx.doi.org/10.1096/fj.10-154484]
45. Wang, Y.; Billon, C.; Walker, J.K.; Burris, T.P. Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of Autism. ACS Chem. Neurosci.; 2016; 7, pp. 143-148. [DOI: https://dx.doi.org/10.1021/acschemneuro.5b00159]
46. Nicholas, B.; Rudrasingham, V.; Nash, S.; Kirov, G.; Owen, M.J.; Wimpory, D.C. Association of Per1 and Npas2 with autistic disorder: Support for the clock genes/social timing hypothesis. Mol. Psychiatry; 2007; 12, pp. 581-592. [DOI: https://dx.doi.org/10.1038/sj.mp.4001953]
47. Yang, Z.; Matsumoto, A.; Nakayama, K.; Jimbo, E.F.; Kojima, K.; Nagata, K.; Iwamoto, S.; Yamagata, T. Circadian-relevant genes are highly polymorphic in autism spectrum disorder patients. Brain Dev.; 2016; 38, pp. 91-99. [DOI: https://dx.doi.org/10.1016/j.braindev.2015.04.006] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25957987]
48. Dintwa, L.; Hughes, C.E.; Blain, E.J. Importance of mechanical cues in regulating musculoskeletal circadian clock rhythmicity: Implications for articular cartilage. Physiol. Rep.; 2023; 11, e15780. [DOI: https://dx.doi.org/10.14814/phy2.15780]
49. Snelling, S.J.; Forster, A.; Mukherjee, S.; Price, A.J.; Poulsen, R.C. The chondrocyte-intrinsic circadian clock is disrupted in human osteoarthritis. Chronobiol. Int.; 2016; 33, pp. 574-579. [DOI: https://dx.doi.org/10.3109/07420528.2016.1158183]
50. Gossan, N.; Zeef, L.; Hensman, J.; Hughes, A.; Bateman, J.F.; Rowley, L.; Little, C.B.; Piggins, H.D.; Rattray, M.; Boot-Handford, R.P. et al. The circadian clock in murine chondrocytes regulates genes controlling key aspects of cartilage homeostasis. Arthritis Rheum.; 2013; 65, pp. 2334-2345. [DOI: https://dx.doi.org/10.1002/art.38035] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23896777]
51. Tian, Y.; Ming, J. The role of circadian rhythm in osteoporosis; a review. Front. Cell Dev. Biol.; 2022; 10, 960456. [DOI: https://dx.doi.org/10.3389/fcell.2022.960456] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36238690]
52. Fu, L.; Patel, M.S.; Bradley, A.; Wagner, E.F.; Karsenty, G. The molecular clock mediates leptin-regulated bone formation. Cell; 2005; 122, pp. 803-815. [DOI: https://dx.doi.org/10.1016/j.cell.2005.06.028]
53. Maronde, E.; Schilling, A.F.; Seitz, S.; Schinke, T.; Schmutz, I.; van der Horst, G.; Amling, M.; Albrecht, U. The clock genes Period 2 and Cryptochrome 2 differentially balance bone formation. PLoS ONE; 2010; 5, e11527. [DOI: https://dx.doi.org/10.1371/journal.pone.0011527]
54. Takarada, T.; Xu, C.; Ochi, H.; Nakazato, R.; Yamada, D.; Nakamura, S.; Kodama, A.; Shimba, S.; Mieda, M.; Fukasawa, K. et al. Bone Resorption Is Regulated by Circadian Clock in Osteoblasts. J. Bone Miner. Res.; 2017; 32, pp. 872-881. [DOI: https://dx.doi.org/10.1002/jbmr.3053] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27925286]
55. Kondratov, R.V.; Kondratova, A.A.; Gorbacheva, V.Y.; Vykhovanets, O.V.; Antoch, M.P. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev.; 2006; 20, pp. 1868-1873. [DOI: https://dx.doi.org/10.1101/gad.1432206] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16847346]
56. Samsa, W.E.; Vasanji, A.; Midura, R.J.; Kondratov, R.V. Deficiency of circadian clock protein BMAL1 in mice results in a low bone mass phenotype. Bone; 2016; 84, pp. 194-203. [DOI: https://dx.doi.org/10.1016/j.bone.2016.01.006]
57. Xu, C.; Ochi, H.; Fukuda, T.; Sato, S.; Sunamura, S.; Takarada, T.; Hinoi, E.; Okawa, A.; Takeda, S. Circadian Clock Regulates Bone Resorption in Mice. J. Bone Miner. Res.; 2016; 31, pp. 1344-1355. [DOI: https://dx.doi.org/10.1002/jbmr.2803] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26841172]
58. Chellappa, S.L.; Vujovic, N.; Williams, J.S.; Scheer, F. Impact of Circadian Disruption on Cardiovascular Function and Disease. Trends Endocrinol. Metab.; 2019; 30, pp. 767-779. [DOI: https://dx.doi.org/10.1016/j.tem.2019.07.008] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31427142]
59. Curtis, A.M.; Cheng, Y.; Kapoor, S.; Reilly, D.; Price, T.S.; Fitzgerald, G.A. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc. Natl. Acad. Sci. USA; 2007; 104, pp. 3450-3455. [DOI: https://dx.doi.org/10.1073/pnas.0611680104] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17360665]
60. Young, M.E.; Brewer, R.A.; Peliciari-Garcia, R.A.; Collins, H.E.; He, L.; Birky, T.L.; Peden, B.W.; Thompson, E.G.; Ammons, B.J.; Bray, M.S. et al. Cardiomyocyte-specific BMAL1 plays critical roles in metabolism, signaling, and maintenance of contractile function of the heart. J. Biol. Rhythms; 2014; 29, pp. 257-276. [DOI: https://dx.doi.org/10.1177/0748730414543141] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25238855]
61. McGinnis, G.R.; Tang, Y.; Brewer, R.A.; Brahma, M.K.; Stanley, H.L.; Shanmugam, G.; Rajasekaran, N.S.; Rowe, G.C.; Frank, S.J.; Wende, A.R. et al. Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart. J. Mol. Cell Cardiol.; 2017; 110, pp. 80-95. [DOI: https://dx.doi.org/10.1016/j.yjmcc.2017.07.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28736261]
62. Durgan, D.J.; Pulinilkunnil, T.; Villegas-Montoya, C.; Garvey, M.E.; Frangogiannis, N.G.; Michael, L.H.; Chow, C.W.; Dyck, J.R.; Young, M.E. Short communication: Ischemia/reperfusion tolerance is time-of-day-dependent: Mediation by the cardiomyocyte circadian clock. Circ. Res.; 2010; 106, pp. 546-550. [DOI: https://dx.doi.org/10.1161/CIRCRESAHA.109.209346]
63. Crnko, S.; Du Pré, B.C.; Sluijter, J.P.G.; Van Laake, L.W. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat. Rev. Cardiol.; 2019; 16, pp. 437-447. [DOI: https://dx.doi.org/10.1038/s41569-019-0167-4] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30796369]
64. Alon, U. Network motifs: Theory and experimental approaches. Nat. Rev. Genet.; 2007; 8, pp. 450-461. [DOI: https://dx.doi.org/10.1038/nrg2102] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17510665]
65. Lee, C.; Etchegaray, J.P.; Cagampang, F.R.; Loudon, A.S.; Reppert, S.M. Posttranslational mechanisms regulate the mammalian circadian clock. Cell; 2001; 107, pp. 855-867. [DOI: https://dx.doi.org/10.1016/S0092-8674(01)00610-9]
66. Kim, Y.H.; Lazar, M.A. Transcriptional Control of Circadian Rhythms and Metabolism: A Matter of Time and Space. Endocr. Rev.; 2020; 41, pp. 707-732. [DOI: https://dx.doi.org/10.1210/endrev/bnaa014]
67. Yu, X.; Rollins, D.; Ruhn, K.A.; Stubblefield, J.J.; Green, C.B.; Kashiwada, M.; Rothman, P.B.; Takahashi, J.S.; Hooper, L.V. TH17 cell differentiation is regulated by the circadian clock. Science; 2013; 342, pp. 727-730. [DOI: https://dx.doi.org/10.1126/science.1243884] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24202171]
68. Etchegaray, J.P.; Machida, K.K.; Noton, E.; Constance, C.M.; Dallmann, R.; Di Napoli, M.N.; DeBruyne, J.P.; Lambert, C.M.; Yu, E.A.; Reppert, S.M. et al. Casein kinase 1 delta regulates the pace of the mammalian circadian clock. Mol. Cell Biol.; 2009; 29, pp. 3853-3866. [DOI: https://dx.doi.org/10.1128/MCB.00338-09]
69. Anafi, R.C.; Lee, Y.; Sato, T.K.; Venkataraman, A.; Ramanathan, C.; Kavakli, I.H.; Hughes, M.E.; Baggs, J.E.; Growe, J.; Liu, A.C. et al. Machine learning helps identify CHRONO as a circadian clock component. PLoS Biol.; 2014; 12, e1001840. [DOI: https://dx.doi.org/10.1371/journal.pbio.1001840]
70. Goriki, A.; Hatanaka, F.; Myung, J.; Kim, J.K.; Yoritaka, T.; Tanoue, S.; Abe, T.; Kiyonari, H.; Fujimoto, K.; Kato, Y. et al. A novel protein, CHRONO, functions as a core component of the mammalian circadian clock. PLoS Biol.; 2014; 12, e1001839. [DOI: https://dx.doi.org/10.1371/journal.pbio.1001839] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24736997]
71. Annayev, Y.; Adar, S.; Chiou, Y.Y.; Lieb, J.D.; Sancar, A.; Ye, R. Gene model 129 (Gm129) encodes a novel transcriptional repressor that modulates circadian gene expression. J. Biol. Chem.; 2014; 289, pp. 5013-5024. [DOI: https://dx.doi.org/10.1074/jbc.M113.534651]
72. Du, N.H.; Arpat, A.B.; De Matos, M.; Gatfield, D. MicroRNAs shape circadian hepatic gene expression on a transcriptome-wide scale. Elife; 2014; 3, e02510. [DOI: https://dx.doi.org/10.7554/eLife.02510] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24867642]
73. Wang, H.; Fan, Z.; Zhao, M.; Li, J.; Lu, M.; Liu, W.; Ying, H.; Liu, M.; Yan, J. Oscillating primary transcripts harbor miRNAs with circadian functions. Sci. Rep.; 2016; 6, 21598. [DOI: https://dx.doi.org/10.1038/srep21598]
74. Na, Y.J.; Sung, J.H.; Lee, S.C.; Lee, Y.J.; Choi, Y.J.; Park, W.Y.; Shin, H.S.; Kim, J.H. Comprehensive analysis of microRNA-mRNA co-expression in circadian rhythm. Exp. Mol. Med.; 2009; 41, pp. 638-647. [DOI: https://dx.doi.org/10.3858/emm.2009.41.9.070]
75. Cheng, H.Y.; Papp, J.W.; Varlamova, O.; Dziema, H.; Russell, B.; Curfman, J.P.; Nakazawa, T.; Shimizu, K.; Okamura, H.; Impey, S. et al. microRNA modulation of circadian-clock period and entrainment. Neuron; 2007; 54, pp. 813-829. [DOI: https://dx.doi.org/10.1016/j.neuron.2007.05.017] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17553428]
76. Gatfield, D.; Le Martelot, G.; Vejnar, C.E.; Gerlach, D.; Schaad, O.; Fleury-Olela, F.; Ruskeepää, A.L.; Oresic, M.; Esau, C.C.; Zdobnov, E.M. et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes. Dev.; 2009; 23, pp. 1313-1326. [DOI: https://dx.doi.org/10.1101/gad.1781009]
77. Kojima, S.; Sher-Chen, E.L.; Green, C.B. Circadian control of mRNA polyadenylation dynamics regulates rhythmic protein expression. Genes. Dev.; 2012; 26, pp. 2724-2736. [DOI: https://dx.doi.org/10.1101/gad.208306.112]
78. Gendreau, K.L.; Unruh, B.A.; Zhou, C.; Kojima, S. Identification and Characterization of Transcripts Regulated by Circadian Alternative Polyadenylation in Mouse Liver. G3; 2018; 8, pp. 3539-3548. [DOI: https://dx.doi.org/10.1534/g3.118.200559]
79. Xu, W.; Li, X. Regulation of Pol II Pausing during Daily Gene Transcription in Mouse Liver. Biology; 2023; 12, 1107. [DOI: https://dx.doi.org/10.3390/biology12081107] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37626993]
80. Wang, H.; Fan, Z.; Shliaha, P.V.; Miele, M.; Hendrickson, R.C.; Jiang, X.; Helin, K. H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. Nature; 2023; 615, pp. 339-348. [DOI: https://dx.doi.org/10.1038/s41586-023-05780-8] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36859550]
81. Vollmers, C.; Schmitz, R.J.; Nathanson, J.; Yeo, G.; Ecker, J.R.; Panda, S. Circadian oscillations of protein-coding and regulatory RNAs in a highly dynamic mammalian liver epigenome. Cell Metab.; 2012; 16, pp. 833-845. [DOI: https://dx.doi.org/10.1016/j.cmet.2012.11.004]
82. Du, S.; Chen, L.; Ge, L.; Huang, W. A Novel Loop: Mutual Regulation Between Epigenetic Modification and the Circadian Clock. Front. Plant Sci.; 2019; 10, 22. [DOI: https://dx.doi.org/10.3389/fpls.2019.00022] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30761168]
83. Yang, P.; Wang, J.; Huang, F.Y.; Yang, S.; Wu, K. The Plant Circadian Clock and Chromatin Modifications. Genes; 2018; 9, 561. [DOI: https://dx.doi.org/10.3390/genes9110561] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30463332]
84. Hung, F.Y.; Chen, F.F.; Li, C.; Chen, C.; Lai, Y.C.; Chen, J.H.; Cui, Y.; Wu, K. The Arabidopsis LDL1/2-HDA6 histone modification complex is functionally associated with CCA1/LHY in regulation of circadian clock genes. Nucleic Acids Res.; 2018; 46, pp. 10669-10681. [DOI: https://dx.doi.org/10.1093/nar/gky749] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30124938]
85. Greer, E.L.; Shi, Y. Histone methylation: A dynamic mark in health, disease and inheritance. Nat. Rev. Genet.; 2012; 13, pp. 343-357. [DOI: https://dx.doi.org/10.1038/nrg3173]
86. Heintzman, N.D.; Hon, G.C.; Hawkins, R.D.; Kheradpour, P.; Stark, A.; Harp, L.F.; Ye, Z.; Lee, L.K.; Stuart, R.K.; Ching, C.W. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature; 2009; 459, pp. 108-112. [DOI: https://dx.doi.org/10.1038/nature07829] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19295514]
87. Guenther, M.G.; Levine, S.S.; Boyer, L.A.; Jaenisch, R.; Young, R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell; 2007; 130, pp. 77-88. [DOI: https://dx.doi.org/10.1016/j.cell.2007.05.042] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17632057]
88. Barski, A.; Cuddapah, S.; Cui, K.; Roh, T.Y.; Schones, D.E.; Wang, Z.; Wei, G.; Chepelev, I.; Zhao, K. High-resolution profiling of histone methylations in the human genome. Cell; 2007; 129, pp. 823-837. [DOI: https://dx.doi.org/10.1016/j.cell.2007.05.009]
89. Lachner, M.; O’Carroll, D.; Rea, S.; Mechtler, K.; Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature; 2001; 410, pp. 116-120. [DOI: https://dx.doi.org/10.1038/35065132]
90. Bannister, A.J.; Zegerman, P.; Partridge, J.F.; Miska, E.A.; Thomas, J.O.; Allshire, R.C.; Kouzarides, T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature; 2001; 410, pp. 120-124. [DOI: https://dx.doi.org/10.1038/35065138] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11242054]
91. Duong, H.A.; Weitz, C.J. Temporal orchestration of repressive chromatin modifiers by circadian clock Period complexes. Nat. Struct. Mol. Biol.; 2014; 21, pp. 126-132. [DOI: https://dx.doi.org/10.1038/nsmb.2746] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24413057]
92. Rada-Iglesias, A.; Bajpai, R.; Swigut, T.; Brugmann, S.A.; Flynn, R.A.; Wysocka, J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature; 2011; 470, pp. 279-283. [DOI: https://dx.doi.org/10.1038/nature09692]
93. Creyghton, M.P.; Cheng, A.W.; Welstead, G.G.; Kooistra, T.; Carey, B.W.; Steine, E.J.; Hanna, J.; Lodato, M.A.; Frampton, G.M.; Sharp, P.A. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA; 2010; 107, pp. 21931-21936. [DOI: https://dx.doi.org/10.1073/pnas.1016071107] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21106759]
94. Fujisawa, T.; Filippakopoulos, P. Functions of bromodomain-containing proteins and their roles in homeostasis and cancer. Nat. Rev. Mol. Cell Biol.; 2017; 18, pp. 246-262. [DOI: https://dx.doi.org/10.1038/nrm.2016.143]
95. Belkina, A.C.; Denis, G.V. BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer; 2012; 12, pp. 465-477. [DOI: https://dx.doi.org/10.1038/nrc3256] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22722403]
96. Lazar, M.A. Nuclear receptor corepressors. Nucl. Recept. Signal.; 2003; 1, e001. [DOI: https://dx.doi.org/10.1621/nrs.01001]
97. Watson, P.J.; Fairall, L.; Santos, G.M.; Schwabe, J.W. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature; 2012; 481, pp. 335-340. [DOI: https://dx.doi.org/10.1038/nature10728]
98. Guenther, M.G.; Barak, O.; Lazar, M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell Biol.; 2001; 21, pp. 6091-6101. [DOI: https://dx.doi.org/10.1128/MCB.21.18.6091-6101.2001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11509652]
99. Guenther, M.G.; Lane, W.S.; Fischle, W.; Verdin, E.; Lazar, M.A.; Shiekhattar, R. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes. Dev.; 2000; 14, pp. 1048-1057. [DOI: https://dx.doi.org/10.1101/gad.14.9.1048] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10809664]
100. Feng, D.; Liu, T.; Sun, Z.; Bugge, A.; Mullican, S.E.; Alenghat, T.; Liu, X.S.; Lazar, M.A. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science; 2011; 331, pp. 1315-1319. [DOI: https://dx.doi.org/10.1126/science.1198125] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21393543]
101. Zhang, Y.; Fang, B.; Emmett, M.J.; Damle, M.; Sun, Z.; Feng, D.; Armour, S.M.; Remsberg, J.R.; Jager, J.; Soccio, R.E. et al. Gene Regulation. Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock. Science; 2015; 348, pp. 1488-1492. [DOI: https://dx.doi.org/10.1126/science.aab3021]
102. Yin, L.; Lazar, M.A. The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol. Endocrinol.; 2005; 19, pp. 1452-1459. [DOI: https://dx.doi.org/10.1210/me.2005-0057]
103. Sun, Z.; Feng, D.; Fang, B.; Mullican, S.E.; You, S.H.; Lim, H.W.; Everett, L.J.; Nabel, C.S.; Li, Y.; Selvakumaran, V. et al. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol. Cell; 2013; 52, pp. 769-782. [DOI: https://dx.doi.org/10.1016/j.molcel.2013.10.022]
104. You, S.H.; Lim, H.W.; Sun, Z.; Broache, M.; Won, K.J.; Lazar, M.A. Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nat. Struct. Mol. Biol.; 2013; 20, pp. 182-187. [DOI: https://dx.doi.org/10.1038/nsmb.2476]
105. Alenghat, T.; Meyers, K.; Mullican, S.E.; Leitner, K.; Adeniji-Adele, A.; Avila, J.; Bućan, M.; Ahima, R.S.; Kaestner, K.H.; Lazar, M.A. Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature; 2008; 456, pp. 997-1000. [DOI: https://dx.doi.org/10.1038/nature07541]
106. Rutter, J.; Reick, M.; Wu, L.C.; McKnight, S.L. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science; 2001; 293, pp. 510-514. [DOI: https://dx.doi.org/10.1126/science.1060698]
107. Asher, G.; Gatfield, D.; Stratmann, M.; Reinke, H.; Dibner, C.; Kreppel, F.; Mostoslavsky, R.; Alt, F.W.; Schibler, U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell; 2008; 134, pp. 317-328. [DOI: https://dx.doi.org/10.1016/j.cell.2008.06.050]
108. Nakahata, Y.; Kaluzova, M.; Grimaldi, B.; Sahar, S.; Hirayama, J.; Chen, D.; Guarente, L.P.; Sassone-Corsi, P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell; 2008; 134, pp. 329-340. [DOI: https://dx.doi.org/10.1016/j.cell.2008.07.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18662547]
109. Hirayama, J.; Sahar, S.; Grimaldi, B.; Tamaru, T.; Takamatsu, K.; Nakahata, Y.; Sassone-Corsi, P. CLOCK-mediated acetylation of BMAL1 controls circadian function. Nature; 2007; 450, pp. 1086-1090. [DOI: https://dx.doi.org/10.1038/nature06394]
110. Zullo, J.M.; Demarco, I.A.; Piqué-Regi, R.; Gaffney, D.J.; Epstein, C.B.; Spooner, C.J.; Luperchio, T.R.; Bernstein, B.E.; Pritchard, J.K.; Reddy, K.L. et al. DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell; 2012; 149, pp. 1474-1487. [DOI: https://dx.doi.org/10.1016/j.cell.2012.04.035]
111. Poleshko, A.; Shah, P.P.; Gupta, M.; Babu, A.; Morley, M.P.; Manderfield, L.J.; Ifkovits, J.L.; Calderon, D.; Aghajanian, H.; Sierra-Pagán, J.E. et al. Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction. Cell; 2017; 171, pp. 573-587.e14. [DOI: https://dx.doi.org/10.1016/j.cell.2017.09.018] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29033129]
112. Somech, R.; Shaklai, S.; Geller, O.; Amariglio, N.; Simon, A.J.; Rechavi, G.; Gal-Yam, E.N. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. J. Cell Sci.; 2005; 118, pp. 4017-4025. [DOI: https://dx.doi.org/10.1242/jcs.02521] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16129885]
113. Cantó, C.; Gerhart-Hines, Z.; Feige, J.N.; Lagouge, M.; Noriega, L.; Milne, J.C.; Elliott, P.J.; Puigserver, P.; Auwerx, J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature; 2009; 458, pp. 1056-1060. [DOI: https://dx.doi.org/10.1038/nature07813]
114. Rodgers, J.T.; Lerin, C.; Haas, W.; Gygi, S.P.; Spiegelman, B.M.; Puigserver, P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature; 2005; 434, pp. 113-118. [DOI: https://dx.doi.org/10.1038/nature03354] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15744310]
115. Hanover, J.A.; Krause, M.W.; Love, D.C. Bittersweet memories: Linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol.; 2012; 13, pp. 312-321. [DOI: https://dx.doi.org/10.1038/nrm3334] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22522719]
116. Kaasik, K.; Kivimäe, S.; Allen, J.J.; Chalkley, R.J.; Huang, Y.; Baer, K.; Kissel, H.; Burlingame, A.L.; Shokat, K.M.; Ptáček, L.J. et al. Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab.; 2013; 17, pp. 291-302. [DOI: https://dx.doi.org/10.1016/j.cmet.2012.12.017]
117. Li, M.D.; Ruan, H.B.; Hughes, M.E.; Lee, J.S.; Singh, J.P.; Jones, S.P.; Nitabach, M.N.; Yang, X. O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab.; 2013; 17, pp. 303-310. [DOI: https://dx.doi.org/10.1016/j.cmet.2012.12.015] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23395176]
118. Xu, Y.; Padiath, Q.S.; Shapiro, R.E.; Jones, C.R.; Wu, S.C.; Saigoh, N.; Saigoh, K.; Ptácek, L.J.; Fu, Y.H. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature; 2005; 434, pp. 640-644. [DOI: https://dx.doi.org/10.1038/nature03453]
119. Lee, H.M.; Chen, R.; Kim, H.; Etchegaray, J.P.; Weaver, D.R.; Lee, C. The period of the circadian oscillator is primarily determined by the balance between casein kinase 1 and protein phosphatase 1. Proc. Natl. Acad. Sci. USA; 2011; 108, pp. 16451-16456. [DOI: https://dx.doi.org/10.1073/pnas.1107178108]
120. Nam, H.J.; Boo, K.; Kim, D.; Han, D.H.; Choe, H.K.; Kim, C.R.; Sun, W.; Kim, H.; Kim, K.; Lee, H. et al. Phosphorylation of LSD1 by PKCα is crucial for circadian rhythmicity and phase resetting. Mol. Cell; 2014; 53, pp. 791-805. [DOI: https://dx.doi.org/10.1016/j.molcel.2014.01.028]
121. Cantó, C.; Auwerx, J. Calorie restriction: Is AMPK a key sensor and effector?. Physiology; 2011; 26, pp. 214-224. [DOI: https://dx.doi.org/10.1152/physiol.00010.2011]
122. Hardie, D.G. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol.; 2007; 8, pp. 774-785. [DOI: https://dx.doi.org/10.1038/nrm2249] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17712357]
123. Davies, S.P.; Carling, D.; Munday, M.R.; Hardie, D.G. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur. J. Biochem.; 1992; 203, pp. 615-623. [DOI: https://dx.doi.org/10.1111/j.1432-1033.1992.tb16591.x]
124. Lamia, K.A.; Sachdeva, U.M.; DiTacchio, L.; Williams, E.C.; Alvarez, J.G.; Egan, D.F.; Vasquez, D.S.; Juguilon, H.; Panda, S.; Shaw, R.J. et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science; 2009; 326, pp. 437-440. [DOI: https://dx.doi.org/10.1126/science.1172156]
125. Um, J.H.; Yang, S.; Yamazaki, S.; Kang, H.; Viollet, B.; Foretz, M.; Chung, J.H. Activation of 5’-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J. Biol. Chem.; 2007; 282, pp. 20794-20798. [DOI: https://dx.doi.org/10.1074/jbc.C700070200]
126. Wang, J.; Symul, L.; Yeung, J.; Gobet, C.; Sobel, J.; Lück, S.; Westermark, P.O.; Molina, N.; Naef, F. Circadian clock-dependent and -independent posttranscriptional regulation underlies temporal mRNA accumulation in mouse liver. Proc. Natl. Acad. Sci. USA; 2018; 115, pp. E1916-E1925. [DOI: https://dx.doi.org/10.1073/pnas.1715225115]
127. Yoo, S.H.; Mohawk, J.A.; Siepka, S.M.; Shan, Y.; Huh, S.K.; Hong, H.K.; Kornblum, I.; Kumar, V.; Koike, N.; Xu, M. et al. Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm. Cell; 2013; 152, pp. 1091-1105. [DOI: https://dx.doi.org/10.1016/j.cell.2013.01.055] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23452855]
128. Siepka, S.M.; Yoo, S.H.; Park, J.; Song, W.; Kumar, V.; Hu, Y.; Lee, C.; Takahashi, J.S. Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell; 2007; 129, pp. 1011-1023. [DOI: https://dx.doi.org/10.1016/j.cell.2007.04.030] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17462724]
129. Godinho, S.I.; Maywood, E.S.; Shaw, L.; Tucci, V.; Barnard, A.R.; Busino, L.; Pagano, M.; Kendall, R.; Quwailid, M.M.; Romero, M.R. et al. The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science; 2007; 316, pp. 897-900. [DOI: https://dx.doi.org/10.1126/science.1141138] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17463252]
130. Busino, L.; Bassermann, F.; Maiolica, A.; Lee, C.; Nolan, P.M.; Godinho, S.I.; Draetta, G.F.; Pagano, M. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science; 2007; 316, pp. 900-904. [DOI: https://dx.doi.org/10.1126/science.1141194] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17463251]
131. Local, A.; Huang, H.; Albuquerque, C.P.; Singh, N.; Lee, A.Y.; Wang, W.; Wang, C.; Hsia, J.E.; Shiau, A.K.; Ge, K. et al. Identification of H3K4me1-associated proteins at mammalian enhancers. Nat. Genet.; 2018; 50, pp. 73-82. [DOI: https://dx.doi.org/10.1038/s41588-017-0015-6]
132. Rickels, R.; Herz, H.M.; Sze, C.C.; Cao, K.; Morgan, M.A.; Collings, C.K.; Gause, M.; Takahashi, Y.H.; Wang, L.; Rendleman, E.J. et al. Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability. Nat. Genet.; 2017; 49, pp. 1647-1653. [DOI: https://dx.doi.org/10.1038/ng.3965] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28967912]
133. Rada-Iglesias, A. Is H3K4me1 at enhancers correlative or causative?. Nat. Genet.; 2018; 50, pp. 4-5. [DOI: https://dx.doi.org/10.1038/s41588-017-0018-3] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29273804]
134. Kouzarides, T. Chromatin modifications and their function. Cell; 2007; 128, pp. 693-705. [DOI: https://dx.doi.org/10.1016/j.cell.2007.02.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17320507]
135. Cardone, L.; Hirayama, J.; Giordano, F.; Tamaru, T.; Palvimo, J.J.; Sassone-Corsi, P. Circadian clock control by SUMOylation of BMAL1. Science; 2005; 309, pp. 1390-1394. [DOI: https://dx.doi.org/10.1126/science.1110689]
136. Tamaru, T.; Takamatsu, K. Circadian modification network of a core clock driver BMAL1 to harmonize physiology from brain to peripheral tissues. Neurochem. Int.; 2018; 119, pp. 11-16. [DOI: https://dx.doi.org/10.1016/j.neuint.2017.12.013]
137. Liu, X.; Xiao, W.; Jiang, Y.; Zou, L.; Chen, F.; Xiao, W.; Zhang, X.; Cao, Y.; Xu, L.; Zhu, Y. Bmal1 Regulates the Redox Rhythm of HSPB1, and Homooxidized HSPB1 Attenuates the Oxidative Stress Injury of Cardiomyocytes. Oxid. Med. Cell Longev.; 2021; 2021, 5542815. [DOI: https://dx.doi.org/10.1155/2021/5542815]
138. Stangherlin, A.; Reddy, A.B. Regulation of circadian clocks by redox homeostasis. J. Biol. Chem.; 2013; 288, pp. 26505-26511. [DOI: https://dx.doi.org/10.1074/jbc.R113.457564] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23861436]
139. Cavalli, G.; Misteli, T. Functional implications of genome topology. Nat. Struct. Mol. Biol.; 2013; 20, pp. 290-299. [DOI: https://dx.doi.org/10.1038/nsmb.2474] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23463314]
140. Lieberman-Aiden, E.; van Berkum, N.L.; Williams, L.; Imakaev, M.; Ragoczy, T.; Telling, A.; Amit, I.; Lajoie, B.R.; Sabo, P.J.; Dorschner, M.O. et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science; 2009; 326, pp. 289-293. [DOI: https://dx.doi.org/10.1126/science.1181369] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19815776]
141. Aguilar-Arnal, L.; Hakim, O.; Patel, V.R.; Baldi, P.; Hager, G.L.; Sassone-Corsi, P. Cycles in spatial and temporal chromosomal organization driven by the circadian clock. Nat. Struct. Mol. Biol.; 2013; 20, pp. 1206-1213. [DOI: https://dx.doi.org/10.1038/nsmb.2667]
142. Zhao, H.; Sifakis, E.G.; Sumida, N.; Millán-Ariño, L.; Scholz, B.A.; Svensson, J.P.; Chen, X.; Ronnegren, A.L.; Mallet de Lima, C.D.; Varnoosfaderani, F.S. et al. PARP1- and CTCF-Mediated Interactions between Active and Repressed Chromatin at the Lamina Promote Oscillating Transcription. Mol. Cell; 2015; 59, pp. 984-997. [DOI: https://dx.doi.org/10.1016/j.molcel.2015.07.019]
143. Xu, Y.; Guo, W.; Li, P.; Zhang, Y.; Zhao, M.; Fan, Z.; Zhao, Z.; Yan, J. Long-Range Chromosome Interactions Mediated by Cohesin Shape Circadian Gene Expression. PLoS Genet.; 2016; 12, e1005992. [DOI: https://dx.doi.org/10.1371/journal.pgen.1005992] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27135601]
144. Kim, Y.H.; Marhon, S.A.; Zhang, Y.; Steger, D.J.; Won, K.J.; Lazar, M.A. Rev-erbα dynamically modulates chromatin looping to control circadian gene transcription. Science; 2018; 359, pp. 1274-1277. [DOI: https://dx.doi.org/10.1126/science.aao6891] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29439026]
145. Mermet, J.; Yeung, J.; Hurni, C.; Mauvoisin, D.; Gustafson, K.; Jouffe, C.; Nicolas, D.; Emmenegger, Y.; Gobet, C.; Franken, P. et al. Clock-dependent chromatin topology modulates circadian transcription and behavior. Genes. Dev.; 2018; 32, pp. 347-358. [DOI: https://dx.doi.org/10.1101/gad.312397.118] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29572261]
146. Luger, K.; Mäder, A.W.; Richmond, R.K.; Sargent, D.F.; Richmond, T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature; 1997; 389, pp. 251-260. [DOI: https://dx.doi.org/10.1038/38444]
147. Kornberg, R.D. Chromatin structure: A repeating unit of histones and DNA. Science; 1974; 184, pp. 868-871. [DOI: https://dx.doi.org/10.1126/science.184.4139.868]
148. Durrin, L.K.; Mann, R.K.; Grunstein, M. Nucleosome loss activates CUP1 and HIS3 promoters to fully induced levels in the yeast Saccharomyces cerevisiae. Mol. Cell Biol.; 1992; 12, pp. 1621-1629. [DOI: https://dx.doi.org/10.1128/mcb.12.4.1621-1629.1992] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1549116]
149. Workman, J.L.; Kingston, R.E. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem.; 1998; 67, pp. 545-579. [DOI: https://dx.doi.org/10.1146/annurev.biochem.67.1.545]
150. Bannister, A.J.; Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res.; 2011; 21, pp. 381-395. [DOI: https://dx.doi.org/10.1038/cr.2011.22]
151. Smith, E.; Shilatifard, A. The chromatin signaling pathway: Diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol. Cell; 2010; 40, pp. 689-701. [DOI: https://dx.doi.org/10.1016/j.molcel.2010.11.031] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21145479]
152. Li, G.; Reinberg, D. Chromatin higher-order structures and gene regulation. Curr. Opin. Genet. Dev.; 2011; 21, pp. 175-186. [DOI: https://dx.doi.org/10.1016/j.gde.2011.01.022] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21342762]
153. Fischle, W.; Wang, Y.; Allis, C.D. Histone and chromatin cross-talk. Curr. Opin. Cell Biol.; 2003; 15, pp. 172-183. [DOI: https://dx.doi.org/10.1016/S0955-0674(03)00013-9]
154. Narlikar, G.J.; Fan, H.Y.; Kingston, R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell; 2002; 108, pp. 475-487. [DOI: https://dx.doi.org/10.1016/S0092-8674(02)00654-2] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11909519]
155. de la Serna, I.L.; Ohkawa, Y.; Imbalzano, A.N. Chromatin remodelling in mammalian differentiation: Lessons from ATP-dependent remodellers. Nat. Rev. Genet.; 2006; 7, pp. 461-473. [DOI: https://dx.doi.org/10.1038/nrg1882]
156. Wang, B.; Kettenbach, A.N.; Gerber, S.A.; Loros, J.J.; Dunlap, J.C. Neurospora WC-1 recruits SWI/SNF to remodel frequency and initiate a circadian cycle. PLoS Genet.; 2014; 10, e1004599. [DOI: https://dx.doi.org/10.1371/journal.pgen.1004599] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25254987]
157. Tao, W.; Chen, S.; Shi, G.; Guo, J.; Xu, Y.; Liu, C. SWItch/sucrose nonfermentable (SWI/SNF) complex subunit BAF60a integrates hepatic circadian clock and energy metabolism. Hepatology; 2011; 54, pp. 1410-1420. [DOI: https://dx.doi.org/10.1002/hep.24514] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21725993]
158. Yudkovsky, N.; Logie, C.; Hahn, S.; Peterson, C.L. Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes. Dev.; 1999; 13, pp. 2369-2374. [DOI: https://dx.doi.org/10.1101/gad.13.18.2369] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10500094]
159. Fan, Z.; Zhao, M.; Joshi, P.D.; Li, P.; Zhang, Y.; Guo, W.; Xu, Y.; Wang, H.; Zhao, Z.; Yan, J. A class of circadian long non-coding RNAs mark enhancers modulating long-range circadian gene regulation. Nucleic Acids Res.; 2017; 45, pp. 5720-5738. [DOI: https://dx.doi.org/10.1093/nar/gkx156] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28335007]
160. Duong, H.A.; Robles, M.S.; Knutti, D.; Weitz, C.J. A molecular mechanism for circadian clock negative feedback. Science; 2011; 332, pp. 1436-1439. [DOI: https://dx.doi.org/10.1126/science.1196766] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21680841]
161. Fang, B.; Everett, L.J.; Jager, J.; Briggs, E.; Armour, S.M.; Feng, D.; Roy, A.; Gerhart-Hines, Z.; Sun, Z.; Lazar, M.A. Circadian enhancers coordinate multiple phases of rhythmic gene transcription in vivo. Cell; 2014; 159, pp. 1140-1152. [DOI: https://dx.doi.org/10.1016/j.cell.2014.10.022]
162. Denslow, S.A.; Wade, P.A. The human Mi-2/NuRD complex and gene regulation. Oncogene; 2007; 26, pp. 5433-5438. [DOI: https://dx.doi.org/10.1038/sj.onc.1210611]
163. Xue, Y.; Wong, J.; Moreno, G.T.; Young, M.K.; Côté, J.; Wang, W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell; 1998; 2, pp. 851-861. [DOI: https://dx.doi.org/10.1016/S1097-2765(00)80299-3]
164. Belden, W.J.; Loros, J.J.; Dunlap, J.C. Execution of the Circadian Negative Feedback Loop in Neurospora Requires the Atp-Dependent Chromatin-Remodeling Enzyme Clockswitch. Mol. Cell; 2007; 25, pp. 587-600. [DOI: https://dx.doi.org/10.1016/j.molcel.2007.01.010] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17317630]
165. Cha, J.; Zhou, M.; Liu, Y. CATP is a critical component of the Neurospora circadian clock by regulating the nucleosome occupancy rhythm at the frequency locus. EMBO Rep.; 2013; 14, pp. 923-930. [DOI: https://dx.doi.org/10.1038/embor.2013.131] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23958634]
166. Beytebiere, J.R.; Greenwell, B.J.; Sahasrabudhe, A.; Menet, J.S. Clock-controlled rhythmic transcription: Is the clock enough and how does it work?. Transcription; 2019; 10, pp. 212-221. [DOI: https://dx.doi.org/10.1080/21541264.2019.1673636]
167. Petkau, N.; Budak, H.; Zhou, X.; Oster, H.; Eichele, G. Acetylation of BMAL1 by TIP60 controls BRD4-P-TEFb recruitment to circadian promoters. Elife; 2019; 8, e43235. [DOI: https://dx.doi.org/10.7554/eLife.43235] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31294688]
168. Malik, S.; Roeder, R.G. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet.; 2010; 11, pp. 761-772. [DOI: https://dx.doi.org/10.1038/nrg2901] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20940737]
169. Thomas, M.C.; Chiang, C.M. The general transcription machinery and general cofactors. Crit. Rev. Biochem. Mol. Biol.; 2006; 41, pp. 105-178. [DOI: https://dx.doi.org/10.1080/10409230600648736]
170. Roeder, R.G. 50+ years of eukaryotic transcription: An expanding universe of factors and mechanisms. Nat. Struct. Mol. Biol.; 2019; 26, pp. 783-791. [DOI: https://dx.doi.org/10.1038/s41594-019-0287-x]
171. Hsieh, T.S.; Cattoglio, C.; Slobodyanyuk, E.; Hansen, A.S.; Darzacq, X.; Tjian, R. Enhancer-promoter interactions and transcription are largely maintained upon acute loss of CTCF, cohesin, WAPL or YY1. Nat. Genet.; 2022; 54, pp. 1919-1932. [DOI: https://dx.doi.org/10.1038/s41588-022-01223-8]
172. Richter, W.F.; Nayak, S.; Iwasa, J.; Taatjes, D.J. The Mediator complex as a master regulator of transcription by RNA polymerase II. Nat. Rev. Mol. Cell Biol.; 2022; 23, pp. 732-749. [DOI: https://dx.doi.org/10.1038/s41580-022-00498-3]
173. Suter, D.M.; Molina, N.; Gatfield, D.; Schneider, K.; Schibler, U.; Naef, F. Mammalian genes are transcribed with widely different bursting kinetics. Science; 2011; 332, pp. 472-474. [DOI: https://dx.doi.org/10.1126/science.1198817] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21415320]
174. Rodriguez, J.; Larson, D.R. Transcription in Living Cells: Molecular Mechanisms of Bursting. Annu. Rev. Biochem.; 2020; 89, pp. 189-212. [DOI: https://dx.doi.org/10.1146/annurev-biochem-011520-105250]
175. Lim, B.; Levine, M.S. Enhancer-promoter communication: Hubs or loops?. Curr. Opin. Genet. Dev.; 2021; 67, pp. 5-9. [DOI: https://dx.doi.org/10.1016/j.gde.2020.10.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33202367]
176. McSwiggen, D.T.; Mir, M.; Darzacq, X.; Tjian, R. Evaluating phase separation in live cells: Diagnosis, caveats, and functional consequences. Genes. Dev.; 2019; 33, pp. 1619-1634. [DOI: https://dx.doi.org/10.1101/gad.331520.119] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31594803]
177. Jonkers, I.; Lis, J.T. Getting up to speed with transcription elongation by RNA polymerase II. Nat. Rev. Mol. Cell Biol.; 2015; 16, pp. 167-177. [DOI: https://dx.doi.org/10.1038/nrm3953]
178. Chiu, A.C.; Suzuki, H.I.; Wu, X.; Mahat, D.B.; Kriz, A.J.; Sharp, P.A. Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP. Mol. Cell; 2018; 69, pp. 648-663.e7. [DOI: https://dx.doi.org/10.1016/j.molcel.2018.01.006]
179. Yamaguchi, Y.; Shibata, H.; Handa, H. Transcription elongation factors DSIF and NELF: Promoter-proximal pausing and beyond. Biochim. Biophys. Acta; 2013; 1829, pp. 98-104. [DOI: https://dx.doi.org/10.1016/j.bbagrm.2012.11.007] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23202475]
180. Luo, Z.; Lin, C.; Shilatifard, A. The super elongation complex (SEC) family in transcriptional control. Nat. Rev. Mol. Cell Biol.; 2012; 13, pp. 543-547. [DOI: https://dx.doi.org/10.1038/nrm3417]
181. Chen, Y.; Vos, S.M.; Dienemann, C.; Ninov, M.; Urlaub, H.; Cramer, P. Allosteric transcription stimulation by RNA polymerase II super elongation complex. Mol. Cell; 2021; 81, pp. 3386-3399.e10. [DOI: https://dx.doi.org/10.1016/j.molcel.2021.06.019] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34265249]
182. Price, D.H. Transient pausing by RNA polymerase II. Proc. Natl. Acad. Sci. USA; 2018; 115, pp. 4810-4812. [DOI: https://dx.doi.org/10.1073/pnas.1805129115] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29691322]
183. Kamieniarz-Gdula, K.; Proudfoot, N.J. Transcriptional Control by Premature Termination: A Forgotten Mechanism. Trends Genet.; 2019; 35, pp. 553-564. [DOI: https://dx.doi.org/10.1016/j.tig.2019.05.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31213387]
184. Yu, M.; Yang, W.; Ni, T.; Tang, Z.; Nakadai, T.; Zhu, J.; Roeder, R.G. RNA polymerase II-associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II. Science; 2015; 350, pp. 1383-1386. [DOI: https://dx.doi.org/10.1126/science.aad2338]
185. Kim, J.; Kim, J.A.; McGinty, R.K.; Nguyen, U.T.; Muir, T.W.; Allis, C.D.; Roeder, R.G. The n-SET domain of Set1 regulates H2B ubiquitylation-dependent H3K4 methylation. Mol. Cell; 2013; 49, pp. 1121-1133. [DOI: https://dx.doi.org/10.1016/j.molcel.2013.01.034] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23453808]
186. Valekunja, U.K.; Edgar, R.S.; Oklejewicz, M.; van der Horst, G.T.; O'Neill, J.S.; Tamanini, F.; Turner, D.J.; Reddy, A.B. Histone methyltransferase MLL3 contributes to genome-scale circadian transcription. Proc. Natl. Acad. Sci. USA; 2013; 110, pp. 1554-1559. [DOI: https://dx.doi.org/10.1073/pnas.1214168110] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23297224]
187. Koike, N.; Yoo, S.H.; Huang, H.C.; Kumar, V.; Lee, C.; Kim, T.K.; Takahashi, J.S. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science; 2012; 338, pp. 349-354. [DOI: https://dx.doi.org/10.1126/science.1226339] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22936566]
188. Baxter, M.; Poolman, T.; Cunningham, P.; Hunter, L.; Voronkov, M.; Kitchen, G.B.; Goosey, L.; Begley, N.; Kay, D.; Hespe, A. et al. Circadian clock function does not require the histone methyltransferase MLL3. FASEB J.; 2022; 36, e22356. [DOI: https://dx.doi.org/10.1096/fj.202200368R] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35704036]
189. Fischer, M.; Schade, A.E.; Branigan, T.B.; Müller, G.A.; DeCaprio, J.A. Coordinating gene expression during the cell cycle. Trends Biochem. Sci.; 2022; 47, pp. 1009-1022. [DOI: https://dx.doi.org/10.1016/j.tibs.2022.06.007]
190. Hsiung, C.C.; Bartman, C.R.; Huang, P.; Ginart, P.; Stonestrom, A.J.; Keller, C.A.; Face, C.; Jahn, K.S.; Evans, P.; Sankaranarayanan, L. et al. A hyperactive transcriptional state marks genome reactivation at the mitosis-G1 transition. Genes. Dev.; 2016; 30, pp. 1423-1439. [DOI: https://dx.doi.org/10.1101/gad.280859.116] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27340175]
191. Palozola, K.C.; Donahue, G.; Liu, H.; Grant, G.R.; Becker, J.S.; Cote, A.; Yu, H.; Raj, A.; Zaret, K.S. Mitotic transcription and waves of gene reactivation during mitotic exit. Science; 2017; 358, pp. 119-122. [DOI: https://dx.doi.org/10.1126/science.aal4671]
192. Gaucher, J.; Montellier, E.; Sassone-Corsi, P. Molecular Cogs: Interplay between Circadian Clock and Cell Cycle. Trends Cell Biol.; 2018; 28, pp. 368-379. [DOI: https://dx.doi.org/10.1016/j.tcb.2018.01.006]
193. Bieler, J.; Cannavo, R.; Gustafson, K.; Gobet, C.; Gatfield, D.; Naef, F. Robust synchronization of coupled circadian and cell cycle oscillators in single mammalian cells. Mol. Syst. Biol.; 2014; 10, 739. [DOI: https://dx.doi.org/10.15252/msb.20145218] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25028488]
194. Matsuo, T.; Yamaguchi, S.; Mitsui, S.; Emi, A.; Shimoda, F.; Okamura, H. Control mechanism of the circadian clock for timing of cell division in vivo. Science; 2003; 302, pp. 255-259. [DOI: https://dx.doi.org/10.1126/science.1086271] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12934012]
195. Zhao, X.; Hirota, T.; Han, X.; Cho, H.; Chong, L.W.; Lamia, K.; Liu, S.; Atkins, A.R.; Banayo, E.; Liddle, C. et al. Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα Degradation. Cell; 2016; 165, pp. 1644-1657. [DOI: https://dx.doi.org/10.1016/j.cell.2016.05.012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27238018]
196. Bartman, C.R.; Hamagami, N.; Keller, C.A.; Giardine, B.; Hardison, R.C.; Blobel, G.A.; Raj, A. Transcriptional Burst Initiation and Polymerase Pause Release Are Key Control Points of Transcriptional Regulation. Mol. Cell; 2019; 73, pp. 519-532.e4. [DOI: https://dx.doi.org/10.1016/j.molcel.2018.11.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30554946]
197. Jaeger, M.G.; Schwalb, B.; Mackowiak, S.D.; Velychko, T.; Hanzl, A.; Imrichova, H.; Brand, M.; Agerer, B.; Chorn, S.; Nabet, B. et al. Selective Mediator dependence of cell-type-specifying transcription. Nat. Genet.; 2020; 52, pp. 719-727. [DOI: https://dx.doi.org/10.1038/s41588-020-0635-0] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32483291]
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
; Ge, Xingnan 1 ; Chen, Qianping 1 ; Jia-Da, Li 2 1 Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310000, China;
2 Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China